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 Multifunctional proteins utilize several strategies to interact with different 
partners, resulting in diverse cellular outcomes. Structural, thermodynamic and kinetic 
features of these proteins influence the switch between functions. The Escherichia coli 
biotin protein ligase, BirA, is a bifunctional protein essential for biotin homeostasis. It 
transfers biotin to the biotin carboxyl carrier protein (BCCP) subunit of acetyl-CoA 
carboxylase in its metabolic role or dimerizes and binds the biotin biosynthetic operator 
as a transcriptional repressor. Each function involves forming a protein-protein 
interaction, and because a single surface of BirA is used to form both interactions, the 
two are mutually exclusive. The BirA interaction surface contains several loops, two with 
highly conserved sequences, and the remaining with variable sequences. In this work the 
roles of four loops in facilitating BirA function were investigated. Amino acids from 
surface loops were replaced with alanine to obtain 18 alanine substituted variants. 
Homodimerization energetics measured using sedimentation equilibrium yielded an 8 
 
kcal/mol range for variants from all loops. Steady-state and stopped-flow kinetic assays 
yielded 7 of 18 variants that exhibited slower rates than wild-type in biotin transfer to 
BCCP. The majority of alanine substituted variants are from constant loops. These results 
indicate that the biotin transfer reaction is mediated primarily through the constant loop 
and homodimerization is facilitated by all surface loops. The energetics of transcription 
repression complex assembly, which comprises contributions from dimerization and 
DNA binding, was assessed using DNaseI footprint titrations. Although variants exhibit a 
broad range in total assembly energetics, all dimers bind with similar affinities to DNA, 
implying independence between DNA binding and dimerization domains. The switch 
between functions was also investigated using inhibition DNaseI footprint titrations. A 
direct correlation between inhibition of repression complex assembly and rates of BirA-
BCCP association was observed, reinforcing a kinetic mechanism for the switch between 
BirA functions. These studies indicate that multiple surface loops form the structural 
basis for bifunctionality, and BirA switches between protein-protein interactions through 
a kinetically controlled mechanism. Elucidation of structural and mechanistic aspects of 
the BirA functional switch enhances our understanding of how multifunctionality evolves 
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Chapter 1: Background and Introduction 
1.1 Multiple interactions facilitate cellular processes 
 A combination of interactions, including protein-protein, protein-nucleic acid and 
protein-small ligand interactions, give rise to almost all cellular processes. While most of 
these interactions lead to favorable outcomes, some unexpected and aberrant interactions 
lead to disease. Characterizing these macromolecular interactions provides information 
that can be used to predict binding partners, design new interactions and design drugs. 
This information, in turn, can be used to understand essential cellular pathways, improve 
drug target affinities and efficiencies, and to cure disease. 
 
 Multifunctional proteins can interact with other proteins and with nucleic acids to 
affect different cellular outcomes, such as metabolism, immune response, apoptosis and 
development (1-4). For example, the pyruvate kinase M2 enzyme is an essential 
component of the glycolytic pathway, catalyzing the conversion of phosphoenolpyruvate 
to pyruvate. In addition, this isoform interacts with signaling proteins, transcription 
factors and different oncoproteins in tumor cells leading to signal transduction, 
transcription regulation, glycolysis and tumor growth (5, 6). Protein-nucleic acid 
interactions result in transcription, translation, DNA repair, replication, and mRNA 
processing. The tumor suppressor p53 is one such protein capable of interacting with both 
proteins and nucleic acids to regulate cellular function. Under conditions of DNA damage 
and oxidative stress, p53 is activated through interaction with protein kinases (7, 8). This 




specific DNA sequences involved in DNA repair, apoptosis and senescence (9). The 
unique ability of p53 to interact with both proteins and DNA gives it a multifunctional 
role in tumor suppression. 
 
 Protein-protein and protein-nucleic acid interactions do not necessarily result in 
favorable outcomes (10). Many known human diseases arise from mutations at protein 
interaction interfaces. For example, the interaction of replication protein A, essential for 
DNA repair, replication and recombination, with BRCA2, a protein involved in DNA 
double-strand break repair through the homologous recombination pathway, is inhibited 
due to a mutation in the BRCA2 gene (11), leading to accumulation of DNA breaks that 
can result in breast cancer. Likewise, infection by the papilloma virus can lead to warts, 
cervical cancer and other tumors in humans (10). The E2 viral protein is important for 
replication of the virus in human cells through several interactions (Fig. 1). The E2 C-
terminal domain dimerizes and binds viral DNA, while the N-terminal transactivation 
domain binds the E1 helicase protein, resulting in regulation of viral protein- and DNA-
binding interactions. The transactivation domain also interacts with the human Brd4 
protein, forming a bond between virus and host cells, leading to infection in humans. 
Thus, studying protein interfaces will lead to a better understanding of the mechanisms 












Figure 1. Interactions of the E2 papilloma virus protein. The E2 DNA-binding domain interacts 
with viral DNA, while the transactivation domain interacts with the E1 helicase. The 
transactivation domain also interacts with human Brd4 protein in the first steps of human 
infection. The figure was obtained from (10). 
 
 
 The inhibition of protein-protein interactions has emerged as the latest approach 
in the drug discovery field (12). Traditionally, antibodies have been used to target 




selectivity and affinity (13). Also many drugs are synthesized to target the active site or 
binding site of the ligand to inhibit the reaction (14). Inhibiting protein-protein 
interactions using small compounds result in the inhibition of subsequent steps in the 
pathway, though challenges exist in this method. Protein-protein interaction interfaces are 
usually large and flat with an average contact surface of approximately 1500-3000Å
2
 
(15). Since very few small molecules naturally bind to a protein interaction surface, 
designing and developing new drugs de novo that efficiently disrupt or mimic an 
interaction using such a small fraction of the interface is a daunting task. However, 
“hotspots,” which are residues within certain regions on protein surfaces that contribute 
most to binding energetics have been identified, and are used as targets in drug design. In 
more than 30% of human cancers, RAS, a GTPase important in signaling, has been 
mutated. RAS binds RAF, a kinase that activates the MAP kinase signaling pathway, 
which regulates cell survival, proliferation and apoptosis (16). Small molecule inhibitors 
of the RAS-RAF interaction have been identified, and these drugs could inhibit this 
protein-protein interaction, thereby inhibiting tumor growth (17). Thus, though targeting 
a protein interaction surface to inhibit a protein-protein interaction is challenging, it can 
result in the inhibition of unfavorable reactions in the cell. 
 
 Multifunctional proteins are believed to contribute to one-third of all protein-
protein interactions (18) and the structural basis for multispecifity varies for different 
proteins (19). Loops, due to their conformational flexibility, are important in mediating 
interactions (20). Intrinsically disordered proteins, or intrinsically disordered regions of a 




different interacting partners (21). Binding pockets in proteins also facilitate direct 
interactions with their partners through specific interactions (22). Imperfect packing, flat 
surfaces and bridging water molecules at binding sites also lead to protein-protein 
interactions (23). Hotspots are involved in forming interactions, and often two hotspot 
regions on each protein partner interact with each other to form the protein complex (24). 
In addition, multifunctional proteins can bind to their numerous partners through distinct 
interaction interfaces, thereby utilizing different residues for binding (25). The human 14-
3-3 protein family is comprised of 7 isoforms (β, ε, η, γ, τ, σ and ζ) and is important for 
the regulation of metabolism, cell signaling, apoptosis, stress response and tumor 
formation (26). These proteins bind phosphopeptides in a specific binding site to regulate 
activation, inhibition, stabilization or orientation of its protein partners (27) (Fig. 2). Each 
protein can homodimerize or form a heterodimer with another isoform, and there is 
evidence that dimerization is used to control the cellular activities of the protein. 
Specificity of the seven isoforms for their various binding partners is facilitated through 
flexibility of the molecule, especially of the αG-αI helices and the CD and HI loop 
regions, which allow different peptides to enter the binding site. Thus, a combination of 
factors, including conformational flexibility, binding pocket specificity and protein 








Figure 2. Crystal structure of the 14-3-3 protein dimer. Each monomer is colored blue to red from 
the N to C-terminal domain. The flexible CD and HI loops that are involved in ligand binding are 
labeled. The figure was obtained from (26). 
 
 
 One feature of multifunctional proteins is their ability to switch between functions 
to produce different cellular outcomes. The mechanism of switching between two or 
more functions can be under kinetic or equilibrium control. If under kinetic control, the 
rates of association and dissociation of protein partners controls the switch, while if under 
thermodynamic control, it is the affinities, or equilibrium dissociation constants of the 
interactions that favors one protein-protein interaction over the other. For example, two 
proteins, thrombomodulin (TM) and a monoclonal antibody (mAb), both bind to 




in the same binding site and though this is not a biologically relevant system, the 
thermodynamic and kinetic profiles have been determined for these two protein-protein 
interactions. They have similar binding affinities, but their association and dissociation 
rates are very different. The TM-thrombin reaction is fast and reversible, while the 
thrombin-mAb reaction is slow and almost irreversible. The difference in rates for these 
two interactions implies a kinetically driven mechanism for thrombin functional 
switching. 
 
 The Escherichia coli biotin protein ligase, BirA, is an integral part of the bacterial 
proteome and is an excellent model to study protein multispecifity. BirA utilizes several 
structural elements to switch between two competing protein-protein interactions that 
result in either fatty acid synthesis or transcription repression. The study of the structural 
basis for multispecificity, as well as the mechanism of the switch, has enabled us to better 
understand the evolution of BirA and its central role in the cell. 
 
1.2 Biotin regulatory system in E. coli 
 The biotin regulatory system is centered on biotin protein ligase, called BirA in E. 
coli (Fig. 3). BirA is a bifunctional protein involved in both protein-protein and protein-
DNA interactions in metabolic and transcription repression roles (29, 30). The ligase is 
activated through the sequential binding of two ligands, biotin and ATP, to form the 
intermediate bio-5’-AMP (31). In its metabolic role, holoBirA associates with the biotin 
carboxyl carrier protein (BCCP) subunit of acetyl-CoA carboxylase (ACC) to transfer 




can also homodimerize and bind to the biotin biosynthetic operator to act as a 
transcription repressor (32, 33). The partitioning of BirA between its metabolic and 
transcription regulatory roles is governed by the amount of apoBCCP in the cell, which is 
in turn governed by cell growth rate (34, 35). Since ACC catalyzes the first committed 
step of fatty acid biosynthesis, the faster cells grow, the greater the requirement for 
membrane synthesis. Hence, there is a greater requirement for apoBCCP to be 
biotinylated, partitioning holoBirA towards its metabolic role. During periods of slow 
cell growth, when apoBCCP levels are low, holoBirA dimerizes, binds to DNA and 
represses transcription of biotin biosynthetic genes. In this way, BirA acts as a 




Figure 3. A schematic representation of the biotin regulatory system in E. coli. ApoBirA binds 
biotin and ATP to form bio-5’-AMP, and the resulting holoBirA binds one of two protein partners 




1.3 The BirA structure 
 BirA is a monomer in its unliganded form with a molecular weight of 35.3 kDa, 
and the 321 amino acids are organized into three domains (Fig. 4). The N-terminal 
domain, comprising residues 1-60, contains three α-helices and two antiparallel β-strands 
(36). Two of the helices, a three residue loop and the two β-strands form a winged helix-
turn-helix motif, which is involved in DNA binding. The N-terminal domain is connected 
to the central domain through a linker. The central domain, compromising residues 80-
269, contains a 7-stranded mixed beta-sheet packed against five helices. This domain also 
contains 5 loops and the active site of the protein. The C-terminal domain contains two 
three-stranded antiparallel beta-sheets and comprises residues 271-320. 
 
 The crystal structures of apoBirA (36, 37), BirA bound to biotin (38), as well as 
the dimer bound to biotinol-5’-AMP (btnOH-AMP), a non-hydrolysable analog of bio-5’-
AMP, have been obtained (39). The apoBirA crystal structure contains four disordered 
loops, three of which, including residues 116-124, 140-146 and 193-199, become ordered 
in the biotin-bound structure. The 116-124 loop is known as the biotin binding loop 
(BBL) as the residues in this loop fold over the biotin molecule, thereby positioning it in 
the active site. In the btnOH-AMP bound crystal structure, the fourth loop, from residues 
212-234, is ordered. This loop is known as the adenylate binding loop (ABL) as it folds 









Figure 4. A model of the biotinol-5’-AMP-bound BirA monomer structure. The domains are 
colored: N-terminal domain, cyan; central domain, magenta; C-terminal domain, blue. The linker 
region is colored in yellow. Loops that are disordered in apoBirA are colored black and are 
labeled. The figure was generated using PyMOL (40) with input file 2EWN (39).  
 
 Several surface loops have previously been characterized for their roles in various 
BirA functions. The BBL, which contains the glycine rich sequence GRGRXG is 
conserved in all biotin protein ligases (41). Characterization of three variants from this 
loop, including G115S, R118G and R119W indicate that this loop is important for biotin 
and bio-5’-AMP binding, homodimerization, and DNA binding through defects in self-
assembly (42, 43). The characterization of two variants from two other loops, including 
A146∆ and D197Y, indicated that these two loops are involved in homodimerization and 
DNA binding, again due to defects in protein assembly (43). Further characterization of 




in use of structural information for homo- and heterodimerization, and that residues 
specific for each interaction exist (44). These results indicate that multiple disordered 
surface loops are required for ligand binding, homodimerization and subsequent DNA 
binding and in the interaction with BCCP. Thus, these multifunctional loops facilitate 
various BirA processes and enable BirA to act as a bifunctional protein. 
 
1.4 BirA as a metabolic enzyme 
 BirA transfers biotin onto a conserved lysine residue on a β-turn of BCCP, 
forming an amide linkage between the carboxyl group of biotin and the ε-NH2 group of 
lysine. The structure of the E. coli BCCP87 domain, the C-terminal BCCP fragment 
shown to be functionally equivalent to the full length protein, has been solved, and 
contains two sets of four antiparallel beta-sheets (45-48). The structure of the BirA-
BCCP from the E. coli complex has not been solved, but has been obtained for the 
Pyrococcus horikoshii system (49). A model of the E. coli complex was constructed with 
known structures of holoBirA monomer and apoBCCP87, using the PhBPL-PhBCCP 
complex as template (Fig. 5) (39, 45, 49, 50). While the PhBPL-PhBCCP association is 
believed to occur through main-chain interactions (49), the BirA-BCCP interaction is 







Figure 5. Model of the BirA-BCCP87 complex from E. coli. BirA is colored red, and BCCP87 is 
blue. The figure was constructed using PyMOL (40) with a file constructed by Zachary Wood 
comprising the PDB files 2EWN and 1BDO for BirA and BCCP87, respectively, using the 
PhBPL-PhBCCP file 2EJG as a template.  
 
 E. coli contains only one biotin-dependent carboxylase, ACC, which catalyzes the 
conversion of acetyl-CoA to malonyl-CoA in the first step of fatty acid synthesis (Fig. 6). 
The E. coli ACC is encoded by four independent peptides (51). The BCCP subunit 
contains the site of biotin attachment. The biotin carboxylase (BC) subunit catalyzes the 
carboxylation of biotin through the formation of a carboxyphosphate intermediate from 
bicarbonate and ATP. This intermediate is then attacked by free electrons on the N1 atom 
of biotin to form carboxybiotin (52). The carboxyltransferase (CT), which comprises two 
distantly related CT-α and CT-β subunits (53), transfers the carboxyl group to acetyl-




“swinging-subunit” model, in which the BCCP subunit translocates during catalysis so 
biotin can interact with the BC and CT subunits (54).   
 
 
Figure 6. Reactions catalyzed by the subunits of acetyl-CoA carboxylase. Biotin is carboxylated 
by the BC subunit, and the carboxyl group is transferred by the CT subunit to acetyl CoA to form 
malonyl CoA (51, 52). 
 
 The reaction catalyzed by ACC is the first committed step in fatty acid 
biosynthesis and is the rate-limiting step of this process (55). Long-chain fatty acids 
synthesized from malonyl-CoA are used to produce cellular components, including the 
plasma membrane. All subunits of ACC are important for cell viability, as evidenced by 




target of assay development and drug design due to its integral role in metabolism and 
cell growth (57). 
 
1.5. BirA as a transcription repressor 
 BirA transcription repression complex assembly involves corepressor, bio-5’-
AMP, binding to apoBirA, followed by holoBirA dimerization and site-specific binding 
to the biotin biosynthetic operator, bioO (32, 33, 58, 59). The biotin operator consists of a 
40-base pair inverted palindrome with two overlapping divergent promoters, Pa and Pb 
(Fig. 7a) (58, 60). A crystal structure of the BirA-bioO complex is not available, but 
DNaseI, hydroxyl radical and dimethyl sulfate footprinting have revealed contact regions 
between the protein and DNA (61, 62). The winged helix-turn-helix (wHTH) motif of the 
BirA N-terminal domain binds DNA through several interactions (Fig. 7b). This motif in 
each monomer interacts with the two 12-base pair termini of the operator site. The 
recognition helix of the HTH motif contacts the major groove of DNA, while the wing 
interacts and fits into the minor groove. Mutations in the recognition helix sequence of 
BirA result in loss of the DNA binding function of the repressor (29, 30, 63). The DNA 
binding domain is relatively mobile compared to the remainder of the molecule, while 
poor packing of the wing region lends flexibility to this domain (39). All these factors 











Figure 7. (a) Schematic representation of the E. coli biotin operon. The transcription regulatory 
region is expanded to show the sequence of the biotin operator (boxed region) and the two 
promoters, Pa and Pb. (b) The crystal structure of BirA bound to btnOH-AMP highlighting the 
winged helix-turn-helix motif in cyan. The left figure was rotated 180
o
 to the right and rotated 
upside-down to obtain the figure on the right. The colored loops represent the flexible loops at the 










 The assembly of many transcription repression complexes, including BirA, 
involves coupling of protein-protein and protein-DNA interactions. Several factors 
contribute to the assembly of a repression complex, including the self-assembly of 
protein monomers, the binding of protein oligomers to DNA, and the structural 
rearrangement of the DNA, the protein or the protein-DNA complex to achieve optimal 
arrangement for interaction (64). The bacteriophage lambda cI repressor, for example, 
dimerizes and binds one or more of three lambda operator sites to control the switch 
between lysogenic and lytic phage cycles (65). The step-wise process of repression 
complex assembly involves lambda repressor dimerization followed by DNA binding, 
while further self-assembly of the lambda repressor on DNA can result in tetramers or 
octamers. The dissociation constant for dimer formation is 10
-8
 M, while 100-fold higher 
concentrations are required to form the tetramer and octamer (65). The higher order 
species are involved in cooperative binding to multiple lambda operator sites to mediate 
repression. In this manner, the lambda repressor complex participates in multiple protein-
protein and protein-DNA interactions, resulting in different developmental states. 
 
 
1.6 The BirA functional switch 
 Once holoBirA is formed, the enzyme can partition in one of two directions: it 
can dimerize and bind to the biotin biosynthetic operator, or it can interact with BCCP 
and transfer biotin. The structural, thermodynamic and kinetic bases for the switch have 
been extensively studied. Structurally, both protein-protein interactions utilize the same 




exclusive. Several loops at the dimer interface have been found to be important in 





Figure 8. Models of the BirA-BCCP heterodimer (left) and BirA homodimer (right). The top 
figures were rotated 90
o
 to display cross-sections of the interfaces. Loops that were previously 
studied are colored: blue, 116-124; green, 140-146; pink, 193-199. All models were created using 
PyMOL (40) with the PDB file 2EWN for the homodimer and a file constructed by Zachary 
Wood comprising the PDB files 2EWN and 1BDO for BirA and BCCP87, respectively, using the 










 The thermodynamic basis for the functional switch has been investigated. 
Homodimerization occurs with an equilibrium dissociation constant of 5-10 µM (∆G =    
-7.0 kcal/mol) (59), while heterodimerization occurs at 2-3 µM (∆G = -7.4 kcal/mol). 
Although the energetics are similar, several experimental results led to the conclusion 
that there were distinct chemistries behind these two interactions (44). HoloBirA 
dimerizes when bound to two bio-5’-AMP analogs, biotinol-5’-AMP and biotin 
sulfamoyl 5’-AMP, but apoBCCP does not interact with these ligand-bound BirA 
molecules (44, 66). Further, the structures of the two interfaces indicate that the 
homodimer forms more electrostatic interactions than the heterodimer. Investigation of 
the temperature and salt dependencies of these two interactions indicated that while 
homodimerization is characterized by a large unfavorable enthalpy (41 ±3 kcal/mol) and 
a modest dependence on salt, heterodimerization has a modest unfavorable enthalpy (7 ± 
2 kcal/mol) and no salt dependency (44, 67). The calculated entropies (-T∆S) of homo 
and heterodimerization are -47 and -14 kcal/mol, respectively. Thus, although the 
entropic driving forces for both interactions are favorable, the larger entropy for 
homodimerization has been attributed to solvent release upon dimer formation (67). Since 
the two interactions are isoenergetic, kinetic control for the switch was proposed. 
 
 The kinetic basis for the switch has been investigated by measuring the effect of 
the presence of apoBCCP on the initial rate of holoBirA binding to bioO (68). In the 
presence of apoBCCP, holoBirA can interact with this substrate and transfer biotin to 
form holoBCCP and apoBirA, thus decreasing the pool of holoBirA that interacts with 




protein concentration. Analysis of sedimentation velocity measurements to obtain the 
rates of homodimerization indicates slow kinetics for the monomer-dimer 









respectively (69). These rates are considerably slower than the measured rate of 




(46) which suggests that at sufficiently high 
apoBCCP concentrations, holoBirA partitions towards its metabolic role in a kinetically 
controlled manner. 
 
1.7 Biotin protein ligases from other organisms 
 Biotin protein ligase is wide-spread in all kingdoms of life, with the exception of 
some bacterial species that do not contain biotin-dependent carboxylases, including 
Buchnera sp., Borrelia burgdorferi, Aeropyrum pernix, thermoplasmas, and 
mycoplasmas (70). The birA genes from many species of eubacteria and archaea were 
identified using a similarity search (70). This gene is widely distributed in these two 
domains of life, and based on gene sequence, two types of proteins could be identified, 
those that act as transcription regulators, and those that do not. Presence of an N-terminal 
DNA binding domain with a helix-turn-helix motif was used as the criterion to identify 
ligases with transcription regulatory functions. The DNA binding property of ligases is 
widely distributed in the Bacillus/Clostridium group, gamma-proteobacteria, and archaea. 
The extensive conservation in sequence among eubacteria and archaea makes this protein 
the only transcriptional regulator with a conserved binding signal. Since bifunctional 
ligases are found in both archaea and eubacteria, the oldest ancestor was believed to be 




 Many bacterial ligases and all eukaryotic ligases are monofunctional and contain 
no N-terminal DNA binding motif in their structure. The C-terminal domains of both 
mono- and bifunctional ligases are conserved. For example, the full-length enzymes from 
E. coli and humans show a 10.5% identity and 19% similarity in sequences (72). By 
contrast, alignment of the C-terminal domains only yields 20% identity and 36% 
similarity in sequence, emphasizing the conservation of the catalytic domain among 
ligases. Two of the five surface loops identified in BirA are exceptionally conserved 
among all ligases (Fig. 9). The residues in these two conserved loops are important for 
every BirA function including ligand binding, dimerization and biotin transfer. Due to 
high sequence conservation, similar roles in ligand binding and biotin transfer for these 
constant loops in other organisms are also anticipated.  
 
 
Figure 9. Multiple sequence alignment of biotin protein ligase from different species. The 116-
124 and 170-176 loop sequences show high sequence identity, while the other loops do not. 
Escherichia coli and Salmonella typhi are gamma-proteobacteria, Bacillus subtilis belongs to the 
Bacillus/Clostridium group, Pyrococcus horikoshii is an archaea bacteria, Saccharomyces 
cerevisiae, Arabidopsis thaliana and Homo sapiens are eukaryotes. The sequence alignment was 




1.8 The experimental problem  
 BirA participates in two protein-protein interactions resulting in different 
biological outcomes. Although the structural basis for BirA multispecifity has been 
studied previously for a few loops, a comprehensive analysis of all surface loops in their 
roles in mediating the two interactions was required. Further, assembly of the 
transcription repression complex and the switch between the two protein functions was 
previously studied, but a complete study of the roles of surface loops in facilitating these 
processes was needed. This work focuses on investigating the roles of surface loops in 
various BirA functions. To this end, 18 amino acids from four surface loops were 
replaced with alanine and the variants were purified and characterized.  
 
 Chapter 2 focuses on the thermodynamic and kinetic characterization of the 
surface loop variants. The energetics of homodimerization for all variants were measured 
using sedimentation equilibrium. A range of free energies of dimerization, from -2.4 to    
-10.6 kcal/mol was observed for alanine-substituted variants across all loops. The kinetic 
parameters of the total reaction, comprising both bio-5’-AMP synthesis and subsequent 
biotin transfer to BCCP87 indicated that three variants in the conserved loop 170-176 
were incapable of performing the entire reaction. To determine which step the variants 
were incapable of catalyzing, and to determine the bimolecular association rate constants 
for the BCCP interaction for all variants, stopped flow studies of the second half reaction 
were performed. Seven of the 18 variants were slower than wild-type BirA in biotin 
transfer, indicating that a subset of variants, primarily from the conserved loop, are more 




biotin transfer reaction, and all surface loops co-evolved to support the non-essential 
homodimerization reaction. 
 
 Characterization of the surface loop variants in the functional switch is described 
in Chapter 3. The effects of dimer interface mutations on the total assembly energetics of 
the repression complex were assessed by DNaseI footprint titrations. While a range of 
total assembly energetics was observed, the affinity of each dimer for DNA was very 
similar to wild-type holoBirA dimer, indicating that dimerization energetics determines 
total assembly energetics. Additionally, the impacts of surface loop alanine substitutions 
on the switch between homo- and heterodimerization were investigated using inhibition 
DNaseI footprint titrations. A direct correlation between inhibition of repression complex 
assembly with hetero-association rates was observed, reinforcing the mechanism of the 
switch as a kinetic partitioning between the two protein-protein interactions. 
 
 This work investigated several surface loops involved in mediating BirA 
multispecificity. These loops evolved to support the essential biotin transfer reaction as 
well as the non-essential homodimerization reaction. Moreover, the direct correlation 
observed between inhibition of repression complex assembly and rates of heterodimer 
association reinforces a mechanism of kinetic control for the switch between BirA 
functions. Combined, these results explain how BirA functions as a metabolic enzyme in 
the essential biotin transfer reaction while also regulating levels of biotin by acting as a 






Chapter 2: Structural basis for BirA multispecificity 
The work presented in this chapter was originally published in the Journal of Molecular 
Biology: Poorni R. Adikaram and Dorothy Beckett. Functional Versatility of a Single 




 The ability of the Escherichia coli protein BirA to function as both a metabolic 
enzyme and a transcription repressor relies on use of a single surface for two distinct 
protein:protein interactions. BirA forms a heterodimer with the biotin acceptor protein of 
acetyl-coenzyme A carboxylase and catalyzes post-translational biotinylation.  
Alternatively, it forms a homodimer that binds sequence-specifically to DNA to repress 
transcription initiation at the biotin biosynthetic operon. Several surface loops on BirA, 
two of which exhibit sequence conservation in all biotin protein ligases and the remainder 
of which are highly variable, are located at the two interfaces. The function of these loops 
in both homodimerization and biotin transfer was investigated by characterizing alanine-
substituted variants at 18 positions of one constant and three variable loops. 
Sedimentation equilibrium measurements reveal that 11 of the substitutions, which are 
distributed throughout conserved and variable loops, significantly alter homodimerization 
energetics. By contrast, steady-state and single-turnover kinetic measurements indicate 
that biotin transfer to biotin carboxyl carrier protein is impacted by 7 substitutions, the 




function in biotin transfer also support homodimerization. The results reveal clues about 
the evolution of a single protein surface for use in two distinct functions. 
 
2.2 Introduction 
 Multispecificity in protein:protein interactions provides a mechanism for 
integration of seemingly unrelated cellular processes. For example, through its ability to 
bind to many distinct protein partners, ubiquitin functions in protein turnover, DNA 
repair, cellular trafficking and chromatin remodeling (73). Although general mechanisms, 
including conformational flexibility and intrinsic disorder (19), for achieving 
multispecific protein binding have been identified, the evolution of multispecificity in 
protein interactions remains obscure. One pressing question is how multispecificity is 
achieved without severely impacting function.  
 
 The Escherichia coli biotin protein ligase BirA provides an ideal system for 
investigation of a multispecific protein binding surface (29, 30). BirA binds biotin and 
ATP to catalyze synthesis of bio-5`-AMP, and the resulting enzyme intermediate 
complex (holoBirA) partitions to one of two functions in response to cellular biot in 
demand (Fig. 10). During rapid growth, when demand is high, holoBirA transfers biotin 
to the biotin carboxyl carrier protein (BCCP) subunit of acetyl-coenzyme A (CoA) 
carboxylase, the enzyme that catalyzes the first committed step of fatty acid synthesis 
(35). ApoBCCP provides the direct signal for biotin demand (34) and only upon its 
depletion can holoBirA homodimerize and bind sequence-specifically to the biotin 




(33). The enzyme intermediate, bio-5’-AMP, binding is required for tight 
homodimerization (59, 74). Although posttranslational biotinylation is essential for 
viability, only a subset of biotin protein ligases are also repressors (70).  
 
 
Figure 10. The E. coli biotin regulatory system. BirA catalyzes bio-5`-AMP synthesis from biotin 
and ATP, and the resulting holoBirA either channels biotin to metabolism by linking it to BCCP 
or homodimerizes and binds sequence-specifically to the biotin operator to repress transcription 
of the biotin biosynthetic operon. 
 
 
 A single surface on BirA is used for both heterodimerization and 
homodimerization (Fig. 11a and b) with both dimers forming by extension of a -sheet in 
the BirA central domain (38, 39). Additionally, several BirA surface loops are located in 
the two interfaces. Previous studies reveal that substitution or deletion of residues in a 




binding and homodimerization in vitro (29, 30, 42, 43). A number of these sequence 
changes also affect the interaction with BCCP (44). Due to their limited scope, these 
results were insufficient to draw conclusions about the relationship between the structure 
of the bispecific BirA surface and its two functions. 
 
 Alignment of sequences of bifunctional bacterial ligases provides clues to the 
evolution of bispecific protein:protein interactions in BirA (Fig. 11c). The average 
sequence identity among these ligases ranges from 90 to 21%. However, alignment of 
several interface loop sequences reveals that they fall into two classes designated 
“conserved and variable.” The sequences of conserved loops 116-124 and 170-176 are 
similar in biotin ligases from bacteria to humans, including monofunctional ligases, 
which either do not form homodimers or do so using surfaces distinct from that used by 
EcBirA (49, 75, 76). Consequently, this conservation likely reflects the critical roles of 
these loops in heterodimerization and/or biotin transfer. This does not, however, preclude 
roles for some of the constant loop residues in homodimerization (29, 30, 42-44). By 
contrast, the variable loop sequences, comprising residues 140-146, 193-199, and 280-
283, likely evolved to support homodimerization while not compromising the essential 
heterodimerization function. Furthermore, the sequence variability in these loops for the 








Figure 11. Models of holoBirA-BCCP87 heterodimer (a) and holoBirA homodimer (b). Rotation 
of the molecules by 90
o 
displays cross-sections of the heterodimer interface (bottom left) and 
homodimer interface (bottom right), highlighting the surface loops involved in the two 
interactions. All models were created using PyMOL(40) with input file 2EWN for the homodimer 
and a file constructed by Zachary Wood for the heterodimer. This model, which uses the 
experimentally determined structure of the Pyrococcus horikoshii biotin protein ligase:BCCP 
complex as a template (2EJG) (49), was constructed using the holoBirA monomer coordinates 
from 2EWN (39) and the coordinates for apoBCCP87 (1BDO) (45). (c) Multiple sequence 
alignment of several bifunctional microbial biotin protein ligases performed using ClustalW (40). 






  The hypothesized roles of four of the BirA surface loops, including three variable 
and one constant loop, in bispecific dimerization were investigated by measuring the 
functional consequences of single alanine substitutions for the two reactions. 
Sedimentation equilibrium measurements of alanine variants reveal that substitutions in 
any of the four loops can impact homodimerization and yield dimerization free energies 
spanning a range of 8.0 kcal/mol. By contrast, steady-state and single turnover kinetic 
measurements of biotin transfer indicate large perturbations primarily for alanine 
substitutions in the conserved loops. Additionally, the constant loop residues that 
function in biotin transfer to BCCP also support the homodimerization reaction. These 
results reveal a strategy for acquisition of additional protein interaction potential in a 




2.3 Experimental procedures 
2.3.1 Chemicals and biochemicals  
 All chemicals used in buffer preparation were at least reagent grade. The 
isopropyl--D-thiogalactoside (IPTG), phenylmethylsulfonyl fluoride (PMSF), 
polyethyleneimine (PEI), unlabeled biotin and ATP were purchased from Sigma. The 
1,4-dithio-DL-threitol (DTT) was purchased from Research Organics. Biotin [8, 9- 
3
H] 
was purchased from Perkin Elmer and stored under argon at -70
o
C. ATP was prepared by 
dissolving the disodium salt in water and adjusting the pH to 7.5 and its concentration 






259 nm. The unlabeled biotin stock solution was prepared by dissolving biotin in 10 mM 
Tris HCl, 200 mM KCl, 2.5 mM MgCl2 and adjusting the pH to 7.5 at 20
o
C. The bio-5`-
AMP was synthesized and purified as previously described (31, 58). The 87-amino acid 
C-terminal fragment (BCCP87) of BCCP from acetyl-CoA carboxylase was purified as 
previously described (46). 
 
 
2.3.2 Mutagenesis and expression and purification of BirA variants 
 Site directed mutagenesis was performed using the QuikChange II XL Site-
Directed Mutagenesis kit (Stratagene) using a pBtac2 (Boehringer Mannheim) derivative 
that contains the BirA coding sequence under transcriptional control of the tac promoter. 
A C-terminal (His)6 tag, which has no effect on function, enabled purification of the 
variant proteins away from the chromosomally encoded wtBirA. After DpnI digestion of 
the mutagenized plasmid, the DNA was transformed into XL10-Gold cells (Stratagene), 
and several single colonies were screened for expression. The sequences were confirmed 
for the entire gene. Proteins were purified as previously described (77), with the 
exception that a final Q-Sepharose column step was added. The absorbance at 280 nm 
was used to calculate the concentration of each protein using the molar extinction 




calculated from the amino acid composition (78). Each 
protein was approximately 95% pure, as assessed by SDS-PAGE analysis, and all 
proteins were >90% active as determined by stoichiometric titrations with bio-5`-AMP 





2.3.3 Sedimentation equilibrium measurements   
 Homodimerization of each protein bound to bio-5’-AMP was determined by 
sedimentation equilibrium using a Beckman Coulter Optima XL-1 analytical 
ultracentrifuge with a four-hole An-60 rotor. Standard 12-mm six-hole or 3-mm two-hole 
cells with charcoal-filled Epon centerpieces and sapphire windows were used in all 
experiments. Prior to centrifugation, proteins (~ 400 µl) were exhaustively dialyzed 
against assay buffer [10 mM Tris-HCl (pH 7.5 at 20
o
C), 200 mM KCl and 2.5 mM 
MgCl2]. The bio-5`-AMP, which was diluted into the dialysis buffer immediately before 
sample preparation, was added to protein at a 1.5:1 molar ratio. Samples prepared at three 
protein concentrations were centrifuged at three rotor speeds (79) (ranging from 18,000 
to 26,000 rpm) at 20
o
C. After reaching equilibrium at each speed, the absorbance at 295 
or 300 nm was measured with a step size of 0.001 cm and five replicates per step.   
 
2.3.4 Data analysis of sedimentation equilibrium measurements 
 The individual absorbance versus radius profiles were analyzed separately and 
globally using a single species model to obtain the reduced molecular weight, , using 
the program WinNonLin (80), from which the molecular weight was calculated using the 
following relationship: 










where M is the molecular weight, 

 is the partial specific volume of the protein,  is the 




the absolute temperature. The nine data sets were then globally analyzed using a 























  (2) 
 
where ct is the total concentration at position r,  is the baseline offset, cm(ro) is the 
concentration at the reference radial position ro and m is the reduced molecular weight of 
the monomer. The association constants, which are obtained in absorbance units from the 
analysis, are reported as molar equilibrium dissociation constants or Kdim.  The quality of 
each analysis was assessed by the square root of variance of the fit and the distribution of 
residuals. 
 
2.3.5 Steady-state kinetic measurements   
 Kinetics of biotin transfer as a function of BCCP87 concentration was measured 
by monitoring the incorporation of [
3
H]-biotin into BCCP87. Reactions containing 5 µM 
cold biotin, 60 nM [
3
H]biotin (specific activity, 32.6 Ci/mmol), 2.5 mM ATP, 0.1 mg/ml 
acetylated bovine serum albumin carrier protein (Invitrogen) and a range of apoBCCP87 
concentrations were performed at 20
o
C in assay buffer. After initiation by addition of 
BirA (wild type or variant) that had been preincubated at 20
o
C to a final concentration of 
100 nM (G193A, 50 nM), 20 µl volumes of the reaction were quenched at various time 
points by spotting onto Whatman filter paper that had been pretreated with a solution 
containing 1 mM biotin and 10% trichloroacetic acid (Alfa Aesar) in water and washed as 




vial containing Ready Protein
+
 cocktail (Beckman Coulter), and radioactivity was 
measured by scintillation counting for 10 min.  
 
2.3.6 Data analysis of steady-state kinetic measurements  
 The initial velocity, obtained as the slope of the counts per minute versus time 
plots, versus BCCP87 concentration data were subjected to nonlinear least-squares 
analysis using the Michaelis-Menten equation in GraphPad Prism 4 (83) to obtain Vmax 
and Km. The Vmax and kcat values were converted from counts per minute to micromolar 
biotin using the relation between counts per minute and micromoles obtained from a 
control reaction performed at conditions in which the [
3
H]biotin is quantitatively 
incorporated into BCCP87. 
 
2.3.7 Initial rate measurements of biotin transfer from the intermediate bio-5’-
AMP 
 The rates of BirA-catalyzed biotin transfer from bio-5`-AMP to the BCCP87 
acceptor substrate were measured using a Kintek SF-2001 stopped-flow instrument 
equipped with fluorescence detection. A solution of the enzyme, wild type or alanine 
variant, at a concentration of 1M was first preincubated for at least 15 min with either 
800 nM biotin and 500 µM ATP or 800 nM bio-5`-AMP at 20
o
C. The resulting 
enzyme
.
intermediate complex was rapidly mixed at a 1:1 vol:vol ratio with BCCP87 to 
achieve final concentrations of 400 nM and 10-90 M for BirA
.
bio-5’-AMP and 
apoBCCP87, respectively. Bio-5`-AMP was used for variants K172A, N175A and 




295 nm, and emission was measured above 340 nm using a cutoff filter (Corion Corp.). 
At least four traces were obtained at each BCCP87 concentration.  
 
2.3.8 Data analysis of single-turnover kinetic measurements 
 The fluorescence intensity versus time traces, obtained for each variant at a range 
of BCCP87 concentrations, were analyzed using either a single-exponential or a double-
exponential model to obtain apparent rate(s). Further analysis of the rate versus 
concentration profiles was performed as described in Results. 
 
2.4 Results  
2.4.1 Homodimerization is sensitive to alanine substitution in variable and 
constant loops 
 The effects of alanine substitutions in the variable loops 140-146, 193-199 and 
280-283 and constant loop 170-176 on homodimerization were measured using 
equilibrium analytical ultracentrifugation. The conserved loop comprising residues 116-
124 was not included in the present work because previously published data indicate 
roles for this loop in both homodimerization and the interaction with BCCP (42-44). The 
total number of variants in the four remaining loops was limited to 18 either because only 
non-alanine residues were replaced or the protein could not be purified. Since stable 
dimerization requires binding of the allosteric effector, bio-5’-AMP, all measurements 
were performed on complexes of proteins bound to the adenylate. Saturation was ensured 
by preparing solutions at a 1.5:1 molar excess of bio-5’-AMP:protein in the micromolar 




three protein concentrations were centrifuged at three rotor speeds (Fig. 12), and global 
analysis of the resulting data using a monomer-dimer model provided the equilibrium 
dimerization constant. For each measurement, the agreement between the data and the 
model was assessed from the distributions of the residuals of the fits and the magnitude 





Figure 12. Absorbance versus radius profiles of E140A-bio-5`-AMP obtained at 40 µM protein 
concentration and centrifuged at 18,000 (×), 22,000 (□) and 26,000 (○) rpm. The lines represent 
the best-fit curves obtained from global analysis of three data sets to a monomer-dimer model. 





 Dimerization measurements for all alanine-substituted variants in the four loops 
indicate a broad range of equilibrium constants (Table 1). With the exception of the 
G142A, D176A, I280A, K172A and K194A variants, the sedimentation equilibrium data 
for the proteins are well described by a monomer-dimer model. The equilibrium 




M (Table 1) corresponding to 
Gibbs free energies of -2.5 to -10.6 kcal/mol (Fig. 13a). For the G142A, K172A, D176A, 
and I280A variants, which exhibit weak dimerization (Table 1, Fig. 13a), the 
concentration versus radius profiles yielded only the monomer at the highest loading 
concentration of 150 M. Hence, the reported dimerization constants are lower limits. 
The K194A variant shows the tightest dimerization with a Kdim of approximately 10 nM, 
which corresponds to an energetic enhancement to dimerization of approximately -3.5 
kcal/mol. The large errors in the equilibrium constant and free energy of dimerization for 
this variant (Table 1) reflect the necessity, due to the detection limits of the instrument’s 
absorption optics, of using protein concentrations at which the monomer population was 















































The equilibrium constants were measured in standard buffer [10 mM Tris-HCl (pH 7.50 ± 0.02 at 
20
o
C), 200 mM KCl and 2.5 mM MgCl2] as described in Materials and Methods. In all cases, the 
protein was saturated with bio-5’-AMP. The Gibbs free energies were calculated using the 
equation ∆G
o
 = RTlnKdim 
a
 The errors represent the standard error of two independent experiments  
b
 The Kdim values reported for G142A, K172A, D176A and I280A are lower limits and that for 
K194A is an upper limit. 
c
 The reported uncertainties for each variant were calculated using standard error propagation 
methods.  
 







Wild Type 7 ( ± 3) x 10
-6
 -6.8 ( ± 0.3) 
E140A 22 ( ± 5) x 10
-6
 -6.2 ( ± 0.2) 
Q141A 3 ( ± 2) x 10
-6
 -7.5 ( ± 0.3) 
G142A 17 (± 52) x 10
-3
 -2.4 ( ± 0.9) 
P143A 4 ( ± 1) x 10
-5
 -5.9 ( ± 0.2) 
R170A 4 ( ± 1) x 10
-5
  -6.0 ( ± 0.2) 
V171A 3 ( ± 2) x 10
-7
 -8.8 ( ± 0.6) 
K172A 7 ( ± 4) x 10
-4
 -4.2 ( ± 0.5) 
N175A 6 ( ± 2) x 10
-5
 -5.7 ( ± 0.2) 
D176A 6 ( ± 6) x 10
-3
 -3.0 ( ± 0.4) 
G193A 5 ( ± 4) x 10
-7
  -8.4 ( ± 0.5) 
 K194A 1 ( ± 7) x 10
-8
 -10.6 ( ± 2.4) 
T195A 10 ( ± 4) x 10
-5
 -5.3 ( ± 0.2) 
G196A 5 ( ± 4) x 10
-6
 -7.1 ( ± 0.4) 
D197A 5 ( ± 3) x 10
-4
 -4.5 ( ± 0.3) 
I280A 4 ( ± 3) x 10
-3
 -3.3 ( ± 0.7) 
G281A 9 ( ± 4) x 10
-5
 -5.4 ( ± 0.3) 
D282A 2 ( ± 2) x 10
-6
 -7.8 ( ± 0.6) 
K283A 12 ( ± 7) x 10
-6





Figure 13. Homodimerization energetics and kinetic parameters for biotin transfer to BCCP. (a) 
Gibbs free energies of homodimerization. (b) The kcat/Km values for biotin transfer to BCCP87 
obtained from steady-state measurements. *, not determined. (c) The bimolecular rates of 
association, k1, of variants with BCCP87 obtained from single-turnover kinetic measurements. 
The kinetic parameters obtained for (b) and (c) are shown on a natural logarithmic scale to place 
them on an energy scale. Error bars for each graph represent the 68% confidence intervals. The 
bar color coding in each panel is wtBirA (white) and variable loop 140-146 (black), constant loop 





2.4.2 Two-step biotin transfer to BCCP is sensitive to alanine substitutions in 
primarily the constant loops  
 BirA-catalyzed biotin transfer is a two-step reaction in which the adenylated 
intermediate, bio-5’-AMP, is first synthesized from biotin and ATP, and the biotin is then 
transferred from the adenylate to BCCP. Since any alanine substitution in the loops can, 
in principle, affect either or both of these steps, two assays, one of the overall reaction 
and the second of biotin transfer from the intermediate alone, were employed to evaluate 
the variants. The impact of each substitution was first measured using steady-state kinetic 
measurements of BirA-catalyzed [
3
H]biotin incorporation into a C-terminal fragment of 
the E. coli acetyl-CoA carboxylase BCCP, BCCP87, which is functionally equivalent to 
the full-length BCCP in BirA-catalyzed biotin transfer (46). In the assay, [
3
H]biotin 
incorporation into the acceptor protein is monitored as a function of time in reactions in 
which ATP and total biotin (labeled plus unlabeled) concentrations were constant and in 
which BCCP87 concentration was varied. Biotin and ATP concentration were at 
saturating and Km, respectively (84). For each variant, the dependence of the initial rate, 
obtained from the linear portion of the product versus time curves (Fig. 14a, inset), on 
BCCP87 concentration was analyzed using the Michaelis-Menten formalism to obtain the 
values of Km and kcat (Fig. 14a). The parameters obtained for the variant D197A are 12±2 
µM and 0.08±0.01 s
-1
 for Km and kcat, respectively, identical with those obtained for 
wtBirA of 9±2 µM and 0.060±0.006 s
-1
, respectively.  
 





Figure 14. Kinetics of biotin transfer to BCCP. (a) Steady-state kinetic analysis of the two-step 
BirA-catalyzed biotin transfer reaction. Inset: initial rates of biotin incorporated at 5 µM (■), 25 
µM (▲), 75 µM (▼) and 100 µM (♦) BCCP concentrations. For clarity, only four of seven lines 
are shown. Each data point is an average of two independent measurements with error bars 
representing the standard error. Initial rates versus substrate concentration were subjected to 
nonlinear least-squares analysis using the Michaelis-Menten model. Each initial rate represents 
the average of values measured in two independent experiments, with error bars representing the 
standard error. (b) Stopped-flow measurements of biotin transfer to BCCP in the second half-
reaction. The fluorescence intensity versus time trace for D197A at 90 µM BCCP is shown with 
residuals for a single-exponential model (middle panel) or a double-exponential model (lower 
panel). (c) The dependence of the apparent rate of biotin transfer on apoBCCP concentration. The 
plots obtained for wtBirA (■), T195A (▲) and V171A (▼) are shown. Each data point is the 
average of rates obtained from at least four stopped-flow traces, and the lines represent the best 





Figure 14. (Description on previous page) 
 
 Steady-state measurements of biotin transfer catalyzed by the entire set of variants 
indicate relative insensitivity of the variable loop sequences to amino acid replacement 
(Table 2 and Fig. 13b). By contrast, alanine substitutions in the 170-176 loop yielded 
three proteins, K172A, N175A and D176A, that have no activity in catalyzing biotin 




proteins can, when provided with synthetic intermediate, bio-5’-AMP, catalyze biotin 
transfer to BCCP87 (see below). Among the alanine-substituted variants in the variable 
loops, only two, K194A and G142A, yielded Km values that differ significantly from that 
measured for the parent wild-type protein. The perturbations to Km for the two proteins 
are roughly 5-fold and 20-fold, respectively. The kcat values for biotin transfer catalyzed 
by all variable loop variants are identical to that measured for wtBirA. 
 
 
 Effects of alanine substitutions on the heterodimer interaction were also assessed 
using single-turnover measurements of the second half-reaction. This assay allows 
separation of effects on the interaction of the enzyme intermediate complex with BCCP 
in the second half-reaction from those on the overall reaction, which is particularly 
important for this system because the rate-determining step in the overall reaction 
corresponds to the first half-reaction, bio-5’-AMP synthesis (46, 84, 85). In these 
measurements, preformed BirA-adenylate is rapidly mixed with apoBCCP87, and the 
resulting time-dependent increase in the intrinsic BirA fluorescence signal is monitored 
(Fig. 14b) (46). This increase, which accompanies the conversion of adenylate-bound 
BirA to apoBirA that occurs upon biotin transfer, has been shown to parallel product, 
bioBCCP product, bioBCCP, accumulation (46). Analysis of each transient was 
performed using either a single-exponential or a double-exponential model (Fig. 14b). 
For variants that exhibit double-exponential behavior, the apparent rate of the first, faster 
phase increases with acceptor protein concentration and that of the second phase is 
substrate concentration independent (46). Apparent rate versus BCCP concentration data 




this behavior is that it reflects collision of the enzyme intermediate complex with 
apoBCCP, which, in the kinetic scheme shown below, is governed by the bimolecular 
rate constant k1: 
(3) 
The slope obtained from linear regression of the rate versus acceptor protein 
concentration profiles yields the bimolecular association constant governing ternary 
complex formation, k1 (Fig. 14c), from BirA
.
bio-5’-AMP and BCCP (85). The 
concentration-independent phase, which occurs with a rate of approximately 0.2 s
-1
, is 
assigned to the product dissociation step governed by k2 (46, 85).  
 
 Rate versus concentration profiles for all 18 variants indicate that the majority of 
the proteins behave identically to wild type BirA (Table 2, Fig. 13c). Of the seven 
variants that deviate, four are proteins with substitutions in the constant loop. Only three 
variants with substitutions in variable loops including G142A, K194A and G196A differ 
from wtBirA in biotin transfer from the adenylate. All variants exhibit the same linear 
dependence of apparent rate on substrate concentration that is observed for wild type 
BirA. However, the magnitudes of k1 values obtained for these proteins are 2.5-600 fold 
slower than that of the wild type protein (Table 2), indicating that they are compromised 
in the rate at which they associate with apoBCCP. Moreover, with the exception of 
G196A, for variants that could be assayed using both steady-state and single turnover 
methods, decreases in k1 correlate with increases in KM., consistent with the Michaelis 





Table 2. The steady-state and single-turnover kinetic parameters for BirA-catalyzed 
biotin transfer to BCCP87 



















Wild Type 9 ± 1 0.060 ± 0.003 6700 ± 800 12,800 ± 800 
E140A 8 ± 3 0.07 ± 0.01 8800 ± 3500 13,900 ± 800 
Q141A 9 ± 1 0.07 ± 0.02 7800 ± 2400 16,000 ± 1000 
G142A 214 ± 9 0.05 ± 0.02 230 ± 90 440 ± 10 
P143A 13 ± 1 0.070 ± 0.005 5400 ± 600 14,500 ± 1200 
R170A 16 ± 2 0.080 ± 0.002 5000 ± 600 13,700 ± 800 
V171A 23 ± 6 0.050 ± 0.003 2200 ± 600 1100 ± 100 
K172A N.D.
d
 N.D. N.D. 320 ± 50 
N175A N.D. N.D. N.D. 4100 ± 100 
D176A N.D. N.D. N.D. 20 ± 2 
G193A 11 ± 3 0.070 ± 0.005 6400 ± 1800 12,000 ± 1000 
K194A 64 ± 9 0.090 ± 0.005 1400 ± 200 700 ± 100 
T195A 19 ± 3 0.07 ± 0.01 3700 ± 800 10,400 ± 800 
G196A 8 ± 1 0.070 ± 0.005 8700 ± 1300 5000 ± 100 
D197A 12 ± 2 0.08 ± 0.01 6700 ± 1400 17,000 ± 1000 
I280A 12 ± 1 0.0600 ± 
0.0003 
5000 ± 400 12,500 ± 600 
G281A 20 ± 2 0.09000 ± 
0.00005 
4500 ± 500 14,000 ± 1000 
D282A 9 ± 2 0.060 ± 0.003 6700 ± 1500 14,400 ± 800 
K283A 17 ± 1 0.050 ± 0.001 2900 ± 200 10,100 ± 500 
The kcat, Km and k1 values were measured as described in “Materials and Methods” in standard 
buffer [10 mM Tris-HCl (pH 7.50 ± 0.02 at 20
o
C), 200 mM KCl and 2.5 mM MgCl2].  
a
 The errors represent the standard error of two independent experiments. 
b
 The reported uncertainties were calculated using standard error propagation. 
c
 The errors represent the uncertainties in the linear regression of the kobs versus [apoBCCP87] 
profiles.  
d








 The roles of BirA loop sequences in its two functions were assessed using 
combined sedimentation equilibrium and kinetic analysis of alanine substituted proteins. 
Consistent with the hypothesis that the variable loop sequences support the 
homodimerization required for transcription repression, alanine substitutions in the 140-
146, 193-199, and 280-283 loops have large energetic consequences for 
homodimerization but only minor impact on heterodimerization. Contrary to the 
hypothesized role of constant loops in biotin transfer only, the 170-176 loop sequence 
function in both interactions.  
 
 Previous studies of the thermodynamics of BirA homodimerization and 
heterodimerization indicate that although the Gibbs free energies measured for the two 
interactions at 20
o
C are similar, the underlying enthalpic and entropic contributions are 
very different (44), consistent with distinct structural determinants for the two 
interactions. The measured effects of alanine substitutions in the four surface loops on 
homodimerization and biotin transfer allow mapping of these structural differences (Fig. 
15). Highlighting of loop residues at which alanine substitution results in large 
perturbations to the homointeraction or heterointeraction indicates distinct gross features 
of the two interfaces. Data obtained previously on the 116-124 loop, which functions in 
both homodimerization and biotin transfer, are included in this analysis (42-44). The 
homodimer interface consists of two dyad symmetric sub-interfaces, each of which is 
characterized by continuous interaction between the variable loop residues of one 




interface is bipartite with the constant loops, which constitute the enzyme active site 




Figure 15. The BirA heterodimer (a) and homodimer (b) interfaces with residues that exhibit 
sensitivity to alanine substitution (with k1 rates at least 10 times less than wtBirA, or the Gdim ≥ 
1kcal/mol) highlighted. The color coding is identical with that used for the loops in Fig. 11. The 





 Detailed structural interpretation of the energetic consequences of alanine 
substitutions for homodimerization is complicated by the known inherent flexibility of 
variable loops 140-146 and 193-199 and of the constant loop 116-124, which are 
disordered in the apoBirA monomer structure (36). Thus, alanine substitutions can 
potentially result in altered conformations of any of these loops. Furthermore, for several 
variants, the functional effects may reflect a disruption of intermolecular and/or 
intramolecular interactions. For example, replacement of V171 with alanine renders 
dimerization more favorable by -2 kcal/mol. In the wild-type BirA dimer structure, the 
V171 side chain is packed in the interior of each protein monomer far from the interface. 




W310 leads to a 3.5 kcal/mole penalty for dimerization when the isoleucine is replaced 
by alanine. The D197 side chain interacts electrostatically with R119 in an intermolecular 
interaction, and substitution of D with A results in an energetic penalty to dimerization of 
2.3 kcal/mol. The stabilizing effect of the K194 replacement reflects the relief of charge 
repulsion between the positively charged lysine and multiple arginine side chains in the 
116-124 loop of the opposing monomer. Relative to homodimerization, alanine 
replacement of a small number of residues impacts biotin transfer. The inability of 
constant loop variants K172A, N175A and D176A to synthesize bio-5`-AMP and their 
slow rates of biotin transfer to BCCP likely reflects roles for these side chains in 
positioning of biotin and ATP in the active site, as well as associating with BCCP to 
transfer the biotin from the adenylate. Interpretation of the slow rate of biotin transfer 
observed for the K194A variant is complicated by the fact that it exists as a dimer, which 
competes with apoBCCP binding, at the 500nM concentration required for detection in 
the stopped-flow fluorescence measurements. Nevertheless, in the holoBirA
.
BCCP 
model, the distance between the epsilon amino group of K194 on BirA and the 
carboxylate of E128 of BCCP is consistent with formation of a salt bridge. This 
interaction may, in part, form the basis of the selectivity that is observed in the biotin 
transfer reaction (85).  
 
 The results reported in this work when combined with those of previous studies 
suggest a model for how the surface loops on BirA support bispecific protein:protein 
interactions. First, structural information in constant loops is multifunctional. Alanine 




transfer to the acceptor protein and homodimerization. Previous studies of the second 
constant loop comprising residues 116-124 indicate similar complexity in its function 
with variants exhibiting defects in biotin and bio-5’-AMP binding, heterodimerization 
and homodimerization (42-44). The sequence conservation in these loops reflects their 
critical roles in the multistep posttranslational biotin addition reaction that is required for 
viability. Second, in the homodimer interface, the variable loop sequences complement 
the constant loops. This is illustrated in Fig. 15, which shows that, in the homodimer 
interface, the majority of the variable loop side chains that are functionally sensitive to 
alanine substitution contact constant loop residues. Thus, it is the complementarity of 
variable loop side chains to the constrained residues of the constant loops that enables use 
of a single surface on BirA for two distinct protein:protein interactions. 
  
 The range of homodimerization energetics measured for the loop variants 
illustrates the ease with which the interaction can be significantly altered through minor 
structural changes. These large energetic changes reflect, in part, the 2-fold symmetry of 
the homodimer interface, with each alanine substitution perturbing at least two 
interactions. The large impact on homodimerization coupled with the absence of impact 
of several amino acid changes in the variable loops on heterodimerization/biotin transfer 
prompts consideration of why wild-type BirA did not evolve to homodimerize more 
tightly. From the standpoint of transcription repression alone, tighter dimerization would 
lead to energetically more favorable assembly of the BirA
.
bioO complex and resulting 
greater repression. It is possible that, if homodimerization were too tight, 




viability. Comparison of the results of steady state and single-turnover kinetic 
measurements for the K194A variant supports this possibility. The lack of an effect on 
kcat in the steady-state measurements reflects the experimental design in which reactions 
are initiated by enzyme addition. Upon bio-5’-AMP synthesis, the significantly higher 
apoBCCP concentration ensures that the enzyme intermediate complex collides with 
acceptor protein rather than itself. By contrast, in the single-turnover measurements 
preincubation of the K194A variant in its complex with the adenylate results in 
significantly slower biotin transfer to BCCP than is observed for the wild-type enzyme. 
This slower transfer may be limited by homodimer dissociation. An alternative 
explanation for the relatively weak homodimerization is that very tight dimerization 
would render the repression sensitive to biotin concentrations that are insufficient to 
support viability. Assembly of the repression complex occurs via coupled dimerization of 
the adenylate-bound monomer and binding of the preformed dimer to bioO (33). 
Simulations of the dependence of transcription repression on biotin concentration indicate 
that as the equilibrium dimerization constant for holoBirA becomes tighter, repression 
occurs at lower biotin concentrations (86). These predictions are currently being tested. 
  
 In general, protein surface loops can serve important roles in mediating 
interactions with other proteins. Structure-based sequence alignments of common 
domains have led to the proposal that surface loops evolve to either allow (enable) or 
prevent (disable) an interaction (20). A surface loop on the E. coli guanylate kinase has 
been experimentally demonstrated to promote its oligomerization (87). In some cases 




Alternatively, as observed in BirA, the particular loop sequence is important for tuning 
dimerization energetics (89). However, the variability in 140-146, 193-199 and 280-283 
loop sequences among the bifunctional ligases suggests that many sequences can support 
homodimerization. This apparent tolerance of homodimerization to sequence variation, 
which may be facilitated by the intrinsic structural flexibility of the interface loops, is 
intriguing in light of the complementarity between variable and constant loop side chains 
in the EcBirA homodimer interface (Fig. 15).  
 
 This work demonstrates that variable surface loops evolved to support BirA 
function in the homodimerization required for transcription repression by complementing 
the constant loops, which are constrained because of their essential role in 
posttranslational biotin addition. The results further illustrate that relatively subtle 
changes in surface loop sequence can elicit large energetic changes in protein:protein 
interactions. The observations have implications for both evolution of protein:protein 





Chapter 3: Protein-protein interactions in the BirA functional switch  
3.1 Abstract 
 Many multifunctional proteins switch between different functions in response to 
cellular signals, but the mechanism of control of the switch is not known in most cases. 
The biotin protein ligase from Escherichia coli, BirA, is a bifunctional enzyme involved 
in biotin homeostasis. It transfers biotin onto an acetyl-CoA carboxylase subunit, biotin 
carboxyl carrier protein (BCCP), in its role as a metabolic enzyme, or dimerizes and 
binds to the biotin biosynthetic operator in its role as a transcription repressor. BirA 
forms two mutually exclusive protein-protein interactions using the same protein surface. 
Previous experiments revealed that the interaction surface contains several loops, all of 
which are important for homodimerization, and only a few of which are impacted in their 
rates of association with BCCP. In this work, the role of surface loops in transcription 
repression complex assembly and in the switch between the two interactions was 
investigated using DNaseI footprint titrations. Direct titrations reveal that the energetics 
of repression complex assembly is determined by homodimerization energetics. 
Inhibition footprint titrations reveal a direct correlation between inhibition of repression 
complex assembly and rates of heterodimer association. These results emphasize the 
central role that protein:protein interactions play in regulatory complex assembly and 






 Many proteins are known to carry out more than one cellular function. This 
multifunctionality can provide a mechanism for linking seemingly distinct cellular 
processes such as gene transcription and metabolism. The ability of a protein to switch 
functions frequently reflects swapping of one protein partner for another. For example, 
under normal growth conditions the σ-like (SL) domain of the general stress response 
protein PhyR of Caulobacter crescentus interacts intramolecularly with the PhyR 
receiver domain (90). In stressful conditions the receiver domain is phosphorylated, 
leading to its dissociation from the SL domain, and binding of PhyR to NepR, an anti 
σ
EcfG
 protein. Swapping of these interactions results in transcription activation of stress 
response genes. Understanding the mechanisms of these biological switches requires 
elucidation of the structural, kinetic and thermodynamic rules that govern switching of 
protein partners.  
 
 The Escherichia coli biotin protein ligase, BirA, provides an example of a protein 
that undergoes a functional switch in response to cellular metabolic state (29, 30). BirA 
binds biotin and ATP to synthesize bio-5’-AMP forming holoBirA (Fig. 16). This 
complex either partitions towards biotin transfer to the biotin carboxyl carrier protein 
(BCCP) subunit of acetyl-coA carboxylase (ACC), which catalyzes the first committed 
step of fatty acid synthesis, or it associates with another holoBirA monomer and binds 
site-specifically to DNA to represses transcription of biotin biosynthetic genes (31, 33, 
58). The holoBirA functional switch depends on intracellular apoBCCP concentration, 




fatty acid requirement is high, holoBirA partitions towards its metabolic role. In slow 
growth, with its accompanying lower requirement for fatty acids, holoBirA dimerizes and 
acts as a transcription repressor, thereby inhibiting biotin biosynthesis when it is not 
needed. The BirA functional switch occurs via formation of two distinct protein-protein 
interactions. Homodimerization, which is a prerequisite of DNA binding, is essential for 
transcription repression. Likewise, the hetero interaction with BCCP, a requirement for 




Figure 16. The biotin regulatory system in E. coli. BirA binds biotin and ATP, and the resulting 
BirA
.
bio5’-AMP (holoBirA) either transfers biotin to apoBCCP or dimerizes and binds site-
specifically to the biotin operator (bioO). 
 
 Much is known about the structural basis of the BirA functional switch. The 




bio-5’-AMP, has been determined by X-ray crystallography (39). Although the structure 
of the E. coli BirA-BCCP complex has not been experimentally obtained, a model has 
been constructed from the known structures of holoBirA and apoBCCP87, a C-terminal 
87 biotin-accepting fragment of BCCP (Fig. 17) (45, 46, 50). The crystal structure of the 
BirA-BCCP complex from Pyrococcus horikoshii confirms the validity of the model 
(49). A single BirA surface, which is characterized by several loops (43, 44, 91), is 
utilized for both the hetero- and homodimer complexes, rendering the two interactions 
mutually exclusive. BirA variants with alanine substitutions in four of the loops, 
comprising residues 140-146, 170-176, 193-199 and 280-283, possess a broad range in 
homodimerization energetics relative to wild-type BirA (91). A subset of these variants 
also associates more slowly with BCCP than does wild-type BirA (91). Although 
informative about the structural requirements for the two protein-protein interactions, 
these results do not report on the impact of the loop perturbations on repression complex 
assembly or the functional switch.  
 
Figure 17. Models of the holoBirA
.
BCCP87 heterodimer (left) and holoBirA homodimer (right). 
Amino acids that were replaced with alanine are from loops 140-146 (green), 170-176 (orange), 
193-199 (pink) and 280-283 (purple). Models were created using PyMOL (40) with the input file 




 Mechanistically, the holoBirA switch can theoretically be subject to kinetic or 
equilibrium control. However, results of multiple experiments support kinetic control. 
The two interactions are roughly isoenergetic with equilibrium dissociation constants for 
homodimerization and heterodimerization of 5-10 µM and 2-3 µM, respectively (59, 68, 
69). Measurements of the effect of apoBCCP on the initial rate of holoBirA binding to 
bioO indicated that, depending on its concentration, the acceptor protein decreases the 
final equilibrium occupancy of bioO by holoBirA dimer (68). This is consistent with the 
notion that apoBCCP depletes the pool of holoBirA that is available for 
homodimerization, thereby lowering bioO occupancy. Sedimentation velocity 
measurements of the dynamics of homodimerization indicate very slow interconversion 









, respectively (69). Furthermore, the bimolecular association rate constant for the 




 is considerably faster than the rate 
constant for homodimerization (46). Thus, due to the faster kinetics of 
heterodimerization, at sufficiently high apoBCCP concentrations holoBirA preferentially 
partitions towards biotin transfer.  
 
 In this work, control of the BirA switch was further investigated by measuring the 
effects of perturbations on homo and heterodimerization resulting from alanine 
substitutions in the interacting surface loops on the process. The diverse set of surface 
loop variants at our disposal were used to study the switch. Direct footprinting 
experiments on wild-type and the 18 BirA surface loop variants indicate that the 




energetics. Results of inhibition footprinting experiments indicate a direct correlation 
between inhibition of repression complex assembly and heterodimer association rates. 
This relationship between heterodimerization rates and inhibition of repression complex 
assembly reinforces the mechanism of the BirA functional switch as a kinetic partitioning 
between alternate protein-protein interactions. 
 
3.3 Experimental Procedures 
3.3.1 Chemicals and biochemicals 
 All chemicals were at least reagent grade. The DNaseI was purchased from 
Sigma-Aldrich. The OneTaq HotStart DNA Polymerase and T4 Polynucleotide Kinase 
were purchased from New England Biolabs. The γ
32
P-ATP used for labeling DNA was 
obtained from Perkin Elmer and the dNTPs were purchased from Promega. Biotin and 
ATP were purchased from Sigma-Aldrich and stock solutions were prepared as described 
in (91) and the bio-5’-AMP was synthesized and purified as previously described (31, 
58). The 87-fragment biotin carboxyl carrier protein (BCCP87) was purified as described 
in (46), with the addition of a Hydroxyapatite ULTROL (PALL) column chromatography 
step to remove any trace amounts of DNase in the protein preparation (68). 
 
3.3.2 Expression and purification of BirA variants 
 Mutations in the BirA coding sequences were introduced using the QuikChange II 
XL Site-Directed Mutagenesis Kit (Stratagene) in the pBTac2 plasmid, which contains 
the BirA coding sequence under transcriptional control of the tac promoter. The variant 




the variant from the chromosomally encoded wild-type protein, were purified as 
previously described (77, 91). After purification, the proteins were dialyzed against 
storage buffer [10 mM Tris-HCl (pH 7.50 ± 0.02 at 4
o
C), 200 mM KCl, 0.1 mM 
dithiothreitol and 5% (v/v) glycerol] and stored at -70
o
C. Protein concentrations were 





, calculated from the amino acid composition (78). The proteins were >95% pure 
as assessed by SDS-PAGE analysis, and >90% active in bio-5’-AMP binding, as 
determined by stoichiometric titrations monitored using steady state fluorescence 
emission spectroscopy (58). 
 
3.3.3 Preparation of bioO DNA for DNaseI footprint titrations  
 Labeling of the DNA fragment for footprinting measurements was accomplished 
by polymerase chain reaction amplification of a fragment in which one of the primers 
was 
32
P-labeled. The two primers were designed to flank the HindIII and PstI restriction 
sites of plasmid pBioZ (58, 60). First the HindIIIpBioZ primer (4 µM) was radiolabeled 
using γ-
32
P ATP (0.8 µM) with T4 polynucleotide kinase. The labeling reaction, which 
also contained 10X kinase buffer and unlabeled ATP (0.8 µM) was allowed to proceed 
for 30 min at 37
o
C, and then quenched with the addition of 10 µl formamide dye [80% 
deionized formamide, 1X TBE buffer, 0.02 % (w/v) bromophenol blue, and 0.02 % 
xylene cyanol (w/v)]. The resulting sample was incubated at 95
o
C for 3 minutes (92) and 
the labeled DNA was separated from unincorporated nucleotides by electrophoresis on a 
20% denaturing polyacrylamide gel (29:1 acrylamide/bisacrylamide in 8 M urea) at     




through an Elutip-D column (Schleicher & Schuell), and concentrated by ethanol 
precipitation (93). The PCR for production of the labeled DNA fragment contained 1 nM 
pBioZ plasmid, 100-150 nM of each of the two primers, 200 nM deoxynucleotide 
triphosphates, and 0.05 units of Taq DNA Polymerase in reaction buffer in a total volume 
of 50 µl. The reaction was performed for 30 cycles of 95
o
C for 2 min (1x), 95
o
C for 1 
min, 54
o
C for 1 min, 72
o
C for 1 min (30x) and a final 72
o
C extension for 5 min (1x) and 
the resulting DNA fragment was separated from template and primers by electrophoresis 
on a 1% agarose gel. After locating the band by phosphorimaging, the DNA was electro-
eluted from the gel, purified through an Elutip-D column and concentrated by ethanol 
precipitation. The final labeled DNA was stored in TE buffer at a final concentration of  
≤ 20,000 cpm/µl at 4
o
C for up to one month. 
 
3.3.4 DNaseI footprint titrations 
 The DNaseI footprinting reactions were performed as described in (94), with a 
few modifications. The labeled DNA at a final concentration of 60 pM was combined 
with BirA protein, wild type or variant, at a range of concentrations in binding buffer 
containing 10 mM Tris-HCl (pH 7.5 at 20
o
C), 200 mM KCl, 2.5 mM MgCl2, 1 mM 
CaCl2, 2 µg/ml sonicated calf-thymus DNA, 100 µg/ml bovine serum albumin, 50 µM 
biotin and 500 µM ATP (or bio-5’-AMP at twice the highest final BirA concentration for 
those variants incapable of bio-5’-AMP synthesis). After incubating at 20
o
C for at least 
45 minutes DNA cleavage was initiated by the addition of 5 µl DNase I (diluted to 
0.0028 mg/ml in binding buffer minus the ligands, calf-thymus DNA and BSA), the 




The reaction was quenched by addition of 33 µl of 50 mM Na2EDTA, the sample was 
rapidly vortexed, and the DNA was precipitated by addition of 700 µl of solution 
containing 0.4 M NH4OAc and 50 µg/ml yeast phenylalanyl tRNA in ethanol. After a 20 
minute incubation in a dry ice/ethanol bath the DNA was pelleted by centrifugation at 
13,000 rpm for 20 min and the resulting pellets were washed with 80% ethanol twice. 
The dried pellets were resuspended in 7 µl formamide dye [80% deionized formamide, 
1X TBE buffer, 0.02 % (w/v) bromophenol blue, and 0.02 % xylene cyanol (w/v)], 
samples were heated to 90
o
C for 10 minutes, quick cooled on ice, loaded onto a 10% 
denaturing polyacrylamide gel (19:1 acrylamide/bisacrylamide in 8 M urea), and 
electrophoresed at 93 W. The gel was dried and exposed to a phosphoimager screen for at 
least 36 hours prior to scanning using a STORM phosphorimaging system (Perkin 
Elmer).  
 
3.3.5 Inhibition DNase I footprint titrations  
 The inhibition DNase I footprinting titrations were performed as described in (68, 
94). The holoBirA concentration used in each titration, which was determined from the 
direct DNase I footprinting titrations, is the concentration at which the bioO is just 
saturated with a particular holoBirA variant. All reactions were carried out in binding 
buffer containing 50 µM biotin and 500 µM ATP, or, for variants that are incapable of 
adenylate synthesis, bio-5`-AMP at twice the total BirA concentration. Each reaction 
contained approximately 10,000 cpm of radiolabeled DNA plus BCCP87 at varying 
concentrations in a total reaction volume of 45 µl. These samples, plus a sample of wild-






at least 45 minutes. All proteins, with the exception of K194A and G142A, were pre-
incubated in binding buffer containing biotin and ATP or bio-5’-AMP (please see Results 
for explanation). Binding reactions were initiated by addition of 5 µl BirA to a tube 
containing BCCP87 and operator DNA. After mixing by gentle vortexing the sample was 
incubated at 20
o
C for 80 seconds at which time bioO occupancy was probed by addition 
of 5 µl of DNase I at 0.003 mg/ml and the cleavage reaction was allowed to proceed for 
30 s. All subsequent steps were performed as described above for the direct footprints.  
 
3.3.6 Data analysis 
 For all footprinting images the intensities of the DNA bands in the bioO site were 
quantified relative to a standard band outside of the site (ImageQuant). For the direct 
footprint titrations, the optical densities were used to produce binding isotherms (94), 
which were subjected to non-linear least square analysis (GraphPad Prism 4.0), using the 
following equation  
 
 
          (4) 
to obtain values for KT, the equilibrium constant governing both repressor dimerization 
and dimer binding to bioO. The equilibrium constant for dimer binding to bioO, KbioO, is 
obtained from the total equilibrium constant using the expression KT = KDIM x KbioO, 
where KDIM is the equilibrium association constant for holoBirA dimerization measured 





 The inhibition footprint images were processed as described above with the 
exception that the isotherms were analyzed using the following equation: 
 
 
          (5) 
to obtain Ka,I, the inhibition association constant governing the interaction between 
holoBirA and apoBCCP. The inverse of Ka,I, the inhibition dissociation constant, KI, is 
reported in Results. The KT value used for analysis of each inhibition footprint titration 
was obtained from the direct DNase I footprint titrations as described above. 
 
3.4 Results 
3.4.1 The total repression complex assembly energetics for each BirA variant is 
dictated by the dimerization energetics 
 The effects of amino acid replacements at the dimer interface on the two-step 
assembly of the biotin repressor on bioO were measured using quantitative DNase I 
footprinting. Alanine replacement in the residues of four surface loops, comprising 
residues 140-146, 170-176, 193-199 and 280-283, yields proteins with dimerization free 
energies ranging from -2.4 to -10.6 kcal/mol (91). DNaseI footprint titrations were 
performed to assess how these perturbations to dimerization influence assembly of the 





 Repression complex assembly occurs in two-steps including dimerization of two 
holoBirA monomers followed by binding of this dimer to bioO. The DNaseI footprinting 
experiment reports on the energetics of both steps and the equilibrium association 
constant governing dimer binding to bioO, KbioO, can be calculated using the equilibrium 
dimerization constant, KDIM, obtained from sedimentation equilibrium experiments. In the 
footprinting experiment, each protein is saturated with bio-5’-AMP either through 
inclusion of biotin and ATP or, for those variants incapable of intermediate synthesis, 
direct addition of bio-5’-AMP, and incubated with approximately 60 pM of radiolabeled 
bioO. This low DNA concentration allows for the assumption that the total protein 
concentration in the reaction is equal to the free protein.  
 
 As observed in the DNaseI footprint titration obtained for the G196A variant (Fig. 
18a), with increasing protein concentration, increased occupancy of the bioO site is 
obtained. Quantitation of the band intensities in the operator site as a function of 
holoG196A concentration (Materials and Methods) yields a binding isotherm (Fig. 18b), 
which was subjected to non-linear least squares analysis using Equation 4 to obtain a KT 






Using this total equilibrium constant and the known 
equilibrium dimerization constant for the variant (5 (± 4) x 10
-6 
M), the calculated value 









 obtained for wild 
type BirA. 
 The KT and ∆GT values for wild-type and all 18 variants are shown in Table 3, 




a range of KT and ∆GT values are observed, the calculated KbioO and ∆GbioO values for all 
proteins are similar in magnitude. An approximately 1 kcal/mol difference in ∆GbioO is 
seen for the K194A variant relative to wild-type. However, the dimerization constant 
obtained for this variant was at the upper limit of measurement due to limitations in the 
instrument’s absorption optics (91) and has a large error associated with it. Thus, the 
values of KbioO and ∆GbioO have this same large uncertainty associated with them. 
 
Figure 18. (a) The direct DNase I footprint titration of bioO obtained for BirA G196A (b) The 
isotherm obtained from quantitation of footprinting data obtained for G196A. The solid line 
represents the best-fit curve obtained from non-linear least squares analysis of the data. The 











































The equilibrium constant, KT, was measured in standard buffer [10 mM Tris-HCL (pH 7.50 ± 
0.02 at 20
o
C), 200 mM KCl, 2.5 mM MgCl2, 1 mM CaCl2, 2 µg/ml sonicated calf-thymus DNA, 
100 µg/ml bovine serum albumin, 50 µM biotin and 500 µM ATP (or bio-5’-AMP)] as described 
in “Materials and Methods.”  
a




KT values were calculated using ∆G
o
KT = RTlnKKT 
c














Wild Type 4.0 ( ± 2.0) x 10
15
 -21.0 ( ± 0.4) 
E140A 1.1 ( ± 0.5) x 10
15
 -20.4 ( ± 0.3) 
Q141A 2.3 ( ± 0.9) x 10
15
 -20.8 ( ± 0.2) 




 -16.9 ( ± 0.2) 
P143A 1.86 ( ± 0.01) x 10
14
 -19.400 ( ± 0.002) 
R170A 9.0 ( ± 4.0) x 10
14
 -20.3 ( ± 0.3) 
V171A 5.3 ( ± 2.3) x 10
16
 -22.7 ( ± 0.3) 
K172A 7.3 ( ± 2.1) x 10
13
 -18.8 ( ± 0.2) 
N175A 1.13 ( ± 0.09) x 10
15
 -20.40 ( ± 0.05) 
D176A 1.2 ( ± 0.6) x 10
13
 -17.7 ( ± 0.3) 
G193A 1.4 ( ± 0.3) x 10
16
 -21.9 ( ± 0.1) 
K194A 2.8 ( ± 0.1) x 10
17
 -23.70 ( ± 0.02) 
T195A 2.5 ( ± 0.4) x 10
14
 -19.60 ( ± 0.08) 
G196A 8.0 ( ± 1.0) x 10
15
 -21.6 ( ± 0.1) 
D197A 2.2 ( ± 0.2) x 10
13
 -18.10 ( ± 0.04) 
I280A 1.4 ( ± 0.4) x 10
13
 -17.8 ( ± 0.1) 
G281A 6.0 ( ± 2.0) x 10
14
 -20.1 ( ± 0.2) 




 -21.80 ( ± 0.02) 
K283A 6.52 ( ± 0.05) x 10
14













































 The KbioO value was calculated using the equation KT = KDIM x KbioO, where KDIM was 




KbioO values were calculated using ∆G
o
KbioO = RTlnKKbioO 
c
 The reported uncertainties for each variant were calculated using error propagation.  
 










Wild Type 2.0 ( ± 1.0) x 10
10
 -13.8 ( ± 0.4) 
E140A 2.0 ( ± 0.9) x 10
10
 -13.7 ( ± 0.3) 
Q141A 7.0 ( ± 3.0) x 10
9
 -13.1 ( ± 0.2) 
G142A 4.0 (± 1.0) x 10
10
 -14.2 ( ± 0.2) 
P143A 9.26 ( ± 0.03) x 10
9
 -13.313 ( ± 0.002) 
R170A 3.0 ( ± 1.0) x 10
10
 -13.9 ( ± 0.3) 
V171A 1.4 ( ± 0.6) x 10
10
 -13.5 ( ± 0.3) 
K172A 5.0 ( ± 1.0) x 10
10
 -14.2 ( ± 0.2) 
N175A 6.4 ( ± 0.5) x 10
10
 -14.43 ( ± 0.05) 
D176A 6.0 ( ± 3.0) x 10
10
 -14.4 ( ± 0.3) 
G193A 7.0 ( ± 1.0) x 10
9
 -13.1 ( ± 0.1) 
K194A 3.3 ( ± 0.1) x 10
9
 -12.71 ( ± 0.02) 
T195A 2.6 ( ± 0.3) x 10
10
 -13.9 ( ± 0.1) 
G196A 3.4 ( ± 0.7) x 10
10
 -14.1 ( ± 0.1) 
D197A 9.7 ( ± 0.7) x 10
9
 -13.34 ( ± 0.04) 
I280A 5.0 ( ± 1.0) x 10
10
 -14.3 ( ± 0.1) 
G281A 6.0 ( ± 2.0) x 10
10
 -14.3 ( ± 0.2) 




 -13.61 ( ± 0.02) 
K283A 7.58 ( ± 0.06) x 10
9




3.4.2 The inhibition of biotin repression complex assembly is directly correlated 
with BirA-BCCP association rates  
 The extent to which transcription repression complex assembly by the BirA 
variants is inhibited by apoBCCP87 was determined using inhibition DNaseI 
footprinting. Stopped-flow kinetic measurements indicate that several of the variants with 
alanine substitutions in surface loops are slower than wild-type BirA in their rates of 
association with apoBCCP (91). It is also known that holoBirA homodimerization and 
holoBirA-apoBCCP heterodimerization are roughly isoenergetic, implying that the 
switch between these two protein-protein interactions is kinetically controlled (68, 69). 
The inhibition footprinting experiments were performed to determine the relationship of 
inhibition of BirA repression complex assembly to rates of hetero-association for the 
variants. 
 
 Repression complex assembly involves dimerization of two holoBirA monomers 
and subsequent binding of this dimer to bioO. Addition of apoBCCP87 to this system 
perturbs homodimerization through the association of holoBirA with apoBCCP87 and 
resulting biotin transfer with concomitant conversion of holoBirA to apoBirA, a species 
that dimerizes very weakly (68). By depleting the dimer pool, occupancy of the bioO site 
is also decreased. In the inhibition footprinting experiment, a range of apoBCCP87 
concentrations is used to obtain an inhibition isotherm. Nonlinear least squares analysis 
of the data using Equation 5 (Materials and Methods) yields the inhibition constant, KI, 





 The design of the inhibition footprinting experiment takes into account 
information obtained from direct footprints described above by using a total BirA 
concentration at which the bioO site is just saturated with BirA, a concentration at which 
the system is poised for inhibition by apoBCCP87. As indicated in the inhibition footprint 
obtained for I280A (Fig. 19a.), a loss of the bioO footprint is observed with increasing 
apoBCCP87 concentration. The inhibition isotherm (Fig. 19b) obtained from the data was 
analyzed using non-linear least squares analysis to obtain a KI of 12.0 (± 2.1) x 10
-6
 M, a 
value that is approximately four-fold larger than that obtained for wild type BirA. In 
contrast to wild type BirA, the lower plateau of the I280A inhibition curve is greater than 
zero. As previously shown (68), this plateau in these isotherms depends on the total 
holoBirA concentration employed with higher concentration yielding higher lower 
plateau values. Due to its weaker dimerization, the I280A concentration used in this 
experiment was 1 µM, significantly higher than the 7.5 x 10
-8
 M concentration employed 
for wild type BirA.  
 






Figure 19. (a) The inhibition DNase I footprint titration of bioO obtained for BirA I280A. (b) 
The inhibition isotherm obtained from quantitation of footprinting data for I280A. The solid 








 The inhibition DNaseI footprint titrations were performed on all variants and data 
were analyzed as described above. In the experiment, all variants with the exceptions of 
K194A and G142A were preincubated with sufficient biotin and ATP to obtain saturation 
with bio-5’-AMP, or directly with bio-5’-AMP for those variants incapable of 
intermediate synthesis, at 20
o
C for 45 min before initiation of the inhibition reaction. 
However, when G142A and K194A variants are pre-incubated with ligand, very high 
BCCP87 concentrations, up to 1 mM, were required to observe any inhibition of 
repression complex assembly. However, when preincubated in the absence of ligand, 
inhibition of assembly by these same variants was observed in the same apoBCCP87 
concentration range as observed for wild-type BirA. The KI and ∆GI values obtained for 
all variants are shown in Table 5. While the parameters for many of the variants are 
similar to that obtained for wild-type BirA, some variants including G142A, K172A, 
D176A, K194A and G196A, differ from wild type BirA by approximately 1 kcal/mol or 
















































The inhibition constants and Gibbs free energies were determined as described in “Materials and 
Methods.” 
a
 KI was obtained through analysis of the data to Equation 5. The value obtained from the fit, KA,I 
was inversed to obtain the inhibition dissociation constant reported here. The errors represent the 




I values were calculated using ∆G
o
I = RTlnKI 
c











Wild Type 2.8 ( ± 0.9) x 10
-6
 -7.4 ( ± 0.2) 
E140A 4.0 ( ± 1.0) x 10
-6
 -7.3 ( ± 0.2) 
Q141A 4.0 ( ± 1.0) x 10
-6
 -7.3 ( ± 0.2) 
G142A 15 (± 5) x 10
-6
 -6.5 ( ± 0.2) 
P143A 7.0 ( ± 1.0) x 10
-6
 -6.9 ( ± 0.1) 
R170A 3.8 ( ± 0.2) x 10
-6
 -7.24 ( ± 0.02) 
V171A 9.0 ( ± 2.0) x 10
-6
 -6.8 ( ± 0.1) 
K172A 20 ( ± 0.7) x 10
-6
 -6.21 ( ± 0.02) 
N175A 4.0 ( ± 0.4) x 10
-6
 -7.2 ( ± 0.1) 
D176A 200 ( ± 1) x 10
-6
 -5.022 ( ± 0.003) 
G193A 5.0 ( ± 0.5) x 10
-6
 -7.1 ( ± 0.1) 
K194A 15 ( ± 0.4) x 10
-6
 -6.44 ( ± 0.02) 
T195A 9.0 ( ± 1.0) x 10
-6
 -6.8 ( ± 0.1) 
G196A 22 ( ± 5.0) x 10
-6
 -6.2 ( ± 0.1) 
D197A 9.0 ( ± 0.1) x 10
-6
 -6.735 ( ± 0.005) 
I280A 12 ( ± 2) x 10
-6
 -6.6 ( ± 0.1) 
G281A 6.0 ( ± 0.8) x 10
-6
 -6.9 ( ± 0.1) 




 -7.3 ( ± 0.2) 
K283A 4.85 ( ± 0.02) x 10
-6





 The effects of perturbations to holoBirA homo and heterodimerization on 
repression complex assembly and the switch between the two functions were assessed 
through direct and inhibition DNase I footprinting titrations. The results reveal that the 
total energetics of repression complex assembly can be tuned by homodimerization 
energetics. Furthermore, a direct correlation between heterodimer association rates and 
inhibition of repression complex assembly was observed, reinforcing a mechanism of 
BirA functional switching that is governed by kinetic control. 
 
 Repression complex assembly is a two-step process of holoBirA dimerization 
followed by site-specific binding of the dimer to the biotin operator (33), and the total 
equilibrium constant, KT, obtained from DNaseI footprint titrations provides a measure of 
both steps. Using previously measured values of homodimerization equilibrium constant, 
KDIM, (Table 1) (91), the affinity of the dimer for DNA, KbioO, is calculated from the 
expression KT=KDIM x KbioO.  The variants are characterized by a range of KT values 
(Table 3, Fig. 20a), but the calculated KbioO values are all similar to that obtained for 
wild-type BirA (Table 4, Fig. 20b), consistent with control of total assembly energetics 
by dimerization energetics. The correlation between KT and KDIM in repression complex 
assembly, for which the correlation coefficient is 0.9556, illustrates the control that 











Figure 20. Gibbs free energies of wild-type BirA and all variants for (a) total 














Figure 21. Correlation plots of (a) ln KTOT versus ln KDIM (r
2
 = 0.9556). (b) ln k1 versus ln KI  (r
2
 = 
0.7190). (c) ln KI versus ln KDIM (r
2
 = 0.1702). 
 
 The similarity of the KbioO values for the variants indicates that amino acid 
substitutions in the dimer interface either do not perturb the structure of this interface or 
that the N-terminal domain functions independently of the remainder of the molecule. 




conformation, and this altered conformation could potentially change the affinity of the 
dimer for bioO. However, the observed lack of impact of KbioO values observed for the 
dimer interface variants suggests that the N-terminal domain functions independently. 
This functional independence is consistent with the known ability of the DNA binding 
domain to adopt different positions relative to the dimerization domain. In the btnOH-
AMP bound dimer structure, two DNA-binding domain orientations that differ by 6.6
o
 
relative to the central domain are observed, indicating that this domain is mobile relative 
to the rest of the molecule (36, 39). Additionally, the winged helix-turn-helix motif DNA-
binding domain itself is structurally heterogeneous. The wing region, which fits into the 
minor groove of DNA, is poorly packed or disordered in the absence of DNA (39), 
lending flexibility to the DNA binding region. Thus, the variable arrangement of the 
entire DNA binding domain in the crystal structure suggests independence of the DNA 
binding domain from the dimerization domains which renders the affinity of the 
holoBirA dimer for bioO insensitive to alterations in the dimer interface.  
  
 The role of heterodimerization kinetics in regulating the BirA functional switch 
was investigated by measuring the abilities of the alanine variants to inhibit assembly of 
the repression complex. In the inhibition footprint titrations the presence of apoBCCP 
decreases the final equilibrium bioO occupancy by depleting the pool of holoBirA 
available for homodimerization (68). Using a range of apoBCCP87 concentrations to 
disrupt the holoBirA-bioO interaction, an inhibition constant, KI, was determined for 
each variant. Of the several variants that exhibit inhibition constants greater than wild-




22a and 22b).  Variants with KI values greater than wild type BirA (less negative ln KI 
values) include G142A, K172A, D176A, K194A and G196A, which are all slower in 
hetero association with apoBCCP (Fig. 22a and 22b). The correlation between inhibition 
constant and the bimolecular association rate constant for holoBirA with apoBCCP87 
(Fig. 21b), which is characterized by a correlation coefficient of 0.7190, emphasizes the 




Figure 22. (a) ∆ln KI = ln KI(variant) – ln KI(wt). (b) The bimolecular rates of association, k1, of the 
BirA-BCCP87 interaction (1). The errors for graph (a) were calculated using standard error 







 Theoretically, in the BirA functional switch, a kinetic or thermodynamic 
mechanism could be responsible for one biological outcome over the other. Previous 
studies have shown that homo and heterodimerization are characterized by isoenergetic 
equilibrium constants (59, 68, 69). Further evidence that the switch is not under 
thermodynamic control is presented in Fig. 21c, which shows the absence of a correlation 
between the equilibrium constant for homodimerization and the ability of apoBCCP to 
inhibit binding of a variant to bioO (correlation coefficient = 0.1702). Thus the magnitude 
of the equilibrium constant governing holoBirA homodimerization has no influence on 
the switch.  
 
 A strong relationship between the results obtained from this work and the biology 
of the biotin regulatory system is observed. The rate of any bimolecular process increases 
with increasing component concentrations, and under conditions of fast cell growth and 
high apoBCCP concentrations, the probability that holoBirA binds this substrate is 
higher, resulting in biotin transfer. Under slow growth conditions due to lower apoBCCP 
concentrations, holoBirA partitions towards its transcription repression role, thereby 
switching between its two functions in a kinetically controlled manner (35). Other 
multifunctional proteins employ different structural, kinetic or thermodynamic 
mechanisms to interact with their partners (28, 95), and elucidation of the mechanism of 
switching for these systems requires measurements of the reaction that are relevant to the 
process. In each case, the thermodynamic or kinetic rules that govern the interactions 






Chapter 4: Summary and Future Directions  
  
 The work presented in this thesis focuses on characterizing the roles of surface 
loop variants in a variety of BirA functions including homodimerization, biotin transfer, 
assembly of the transcription repression complex and in controlling the bifunctional 
switch. All surface loops were found to be important for homodimerization and only a 
subset of residues on some surface loops was found to be essential for the biotin transfer 
reaction. Study of repression complex assembly revealed that homodimerization 
energetics determines total assembly energetics. Finally, a direct correlation between 
heterodimer association rates and inhibition of repression complex assembly was 
observed, reinforcing a mechanism of kinetic control in the BirA bifunctional switch.  
 
 The structural basis for BirA bifunctionality is achieved through surface loops. 
The flexibility of these loops and their location at the dimer interface enables them to 
participate in two protein-protein interactions. Two different types of loops termed 
constant and variable were identified based on protein sequence conservation. Constant 
loops have highly conserved sequences among ligases from all organisms and in BirA the 
essential biotin transfer reaction is facilitated by these loops. Based on the high sequence 
conservation and their presence in all biotin protein ligases, we can assume that these 
constant loops facilitate the biotin transfer reaction in all ligases. The variable loop 
sequences show very little homology, even among bifunctional ligases (Fig. 23). These 
loops participate in the homodimerization reaction in BirA, and we can assume that they 




variable loop sequences from bifunctional ligases are so diverse, it is uncertain how 
different loop sequences can evolve to perform the same function as in E. coli BirA. The 
ideal method to investigate this is to perform alanine scanning mutagenesis on loop 
residues from other bifunctional ligases and measure the effects of loop perturbations on 
homodimerization. By studying surface loops from other bifunctional ligases, we can 
understand the evolution of variable loops and determine if, regardless of the sequence, 
these loops facilitate homodimerization as they do for BirA. If not, an investigation of 
other structural strategies used by these bifunctional ligases to enable homodimerization 
without compromising the essential biotin transfer reaction would allow us to understand 





 Figure 23. Multiple sequence alignment of bifunctional bacterial biotin protein ligases 
using ClustalW (72). The constant loop sequences are well conserved and the variable loop 






 Like BirA, many other multifunctional proteins utilize loops to mediate several 
interactions (96, 97). Surface loops do not disrupt folding of the protein and can be used 
in ligand binding and partner recognition as well. Apart from loops, other structural 
strategies can be employed by proteins to interact with different targets including binding 
pockets, intrinsically disordered regions of the protein, hotspots and/or distinct interaction 
interfaces (19). A multispecific protein often co-evolves with its partners to carry out 
specific cellular functions, implying that the structural components used by these proteins 
to facilitate interactions also co-evolved. The structural basis for functional evolution has 
not been studied for most multifunctional proteins, and could provide valuable insight 
into the mechanisms of protein multispecificity. The structural components used to form 
each protein-protein interaction should be identified, and overlap in use of structural 
information would illustrate the structural versatility of the protein in facilitating 
numerous interactions. These studies would provide information about the structure-
function relationship and evolution of multifunctional proteins.  
 
 One feature of multifunctional proteins is their ability to switch between functions 
depending on cellular requirements. Functional switching can be mechanistically under 
equilibrium or kinetic control. A kinetic mechanism implies that the rates of association 
govern protein assembly, and an equilibrium mechanism is governed by affinities for one 
protein-protein interaction over the other. For BirA, a kinetic mechanism of switching 
between two protein-protein interactions was observed. However, for many 
multifunctional proteins the switching mechanism is not known. Studying the basis for 




protein association and the biological outcomes that result from one protein-protein 
interaction over the other. For example, ubiquitin is a protein involved in multiple homo 
and hetero interactions, yet the kinetic or thermodynamic basis for switching between 
partners is not known (98). This information can be used to understand ubiquitin 
assembly, preference for binding partners and ubiquitin functions, including protein 
degradation, cell-cycle regulation, DNA repair and apoptosis (99). Understanding the 
mechanism of functional switching in multifunctional proteins can add to our knowledge 
of cellular processes and explain different biological outcomes. However, complications 
arise when studying the switch mechanism in eukaryotic proteins versus prokaryotic 
proteins due to compartmentalization in eukaryotic systems (100). For example, the 
human biotin protein ligase, holocarboxylase synthetase, or HCS, interacts with five 
different biotin-dependent carboxylases in human cells (51). The kinetic preference of 
HCS for three substrates over the other two was found to be based on the location of the 
carboxylase in the cell (101). Three carboxylases that function in the mitochondria are 
biotinylated faster than two carboxylases found in the cytosol, presumably because the 
cytosolic HCS has less access to mitochondrial carboxylases. Thus, when studying the 
switching mechanism in eukaryotic cells the compartmentalization of protein partners 
should also be considered. 
 
 This work has laid the groundwork for several future studies. The loops studied in 
this work represent only four of eight interfacial loops identified previously (39). The 
study of other loops will provide a complete understanding of the roles of all surface 




domain (Fig. 24) are of particular interest because similar loops were identified in the P. 
horikoshii biotin protein ligase (PhBPL) by sequence alignment and are within contact 
distance to PhBCCP (49). The BirA 309-313 loop is within contact distance to the other 
BirA monomer in the homodimer structure and to BCCP in the heterodimer model (39, 
45, 50). Based on the importance of these loops in mediating the PhBPL-PhBCCP 
interaction, we can speculate on their importance for facilitating BirA homo and 
heterodimerization. The best way to determine this is to perform alanine scanning 
mutagenesis on residues of these loops to determine their roles in BirA functions, and 
thereby also learn more about the role of the C-terminal domain. Also, since only four 
residues from the 116-124 loop were previously studied, a more comprehensive analysis 
of the roles of the residues in this loop can provide information on the importance of this 
conserved loop in BirA functions. Further, obtaining structures of variants already 
characterized will provide a clearer understanding of the effect of alanine substitutions at 
the dimer interface. These structures may provide insight into the structural 
rearrangements that occur due to amino acid replacements that cannot be explained from 
existing structures of the wild-type protein. This may, in turn, help to explain some 
unexpected results obtained from our work, such as the more favorable Gibbs free energy 









 Figure 24. Models of the BirA-BCCP heterodimer (left) and BirA homodimer (right). 
The top figures were rotated 90
o
 to display cross-sections of the interfaces. Two BirA loops 
located at the dimer interface are highlighted: 292-298, cyan; 309-313, red. All models were 
created using PyMOL (40) with the PDB file 2EWN for the homodimer and a file constructed by 
Zachary Wood comprising the PDB files 2EWN and 1BDO for BirA and BCCP87, respectively, 
using the PhBPL-PhBCCP file 2EJG as a template.  
 
 
 In this work, we assumed that the alanine substituted variants from the four 









This is a reasonable assumption, since the biotin-binding and ATP-binding sites 
identified from crystal structures are located far from the dimer interface loops. Yet, a 
study of the ligand binding properties of these variants may yield interesting results, 
especially because in the dimer structure the 193-199 loop from the second monomer and 
the 170-176 loop from the same monomer are within close proximity to the btnOH-AMP 
moiety. It is possible that residues from these loops are required for both ligand binding 
and to position the adenylate in the active site. The ligand binding properties of all 
alanine substituted surface loop variants should be measured to understand the roles of 
these loops in ligand binding and catalysis.  
 
 A diverse set of variants that display very different dimerization properties are at 
our disposal and can be used to study BirA properties in vivo. Through recombineering 
(102), the chromosomal DNA of E. coli can be mutated to code for variants with altered 
dimerization constants, which in turn can be used to study the relationship between in 
vitro measurements and BirA properties in vivo. The wtBirA in vivo concentration is 
estimated to be 40 nM and we can assume that variants transcribed from chromosomal 
DNA will be present at similar concentrations, but this will have to be experimentally 
measured. Variants with very weak dimerization constants, in the upper micromolar to 
millimolar range, will assumedly be unable to dimerize and repress transcription at these 
low in vivo concentrations. These variants can be used to measure the effect of 
uncontrolled biotin production on cell growth/death rates and the biotin transfer reaction. 
Conversely, the chromosome can be mutated to produce BirA variants with very tight 




always be bound to the biotin operator. These variants can be used to determine the effect 
of over-repression of the biotin biosynthetic operator on the essential biotin transfer 
reaction and the switch between functions. Comparison of in vivo and in vitro 
measurements is essential to determine the validity of experiments we perform in the test 
tube.  
 
 In this work the significance of BirA surface loops for homodimerization and 
biotin transfer were investigated. The results provide insight into the evolution of these 
loops to mediate multiple functions and explain a mechanism of switching between two 
functions. We hope this work will be the starting point for future studies of BirA surface 
loops, the study of the evolution of biotin protein ligase, and for studying the mechanisms 
















1. Hohenauer T & Moore AW (2012) The Prdm family: expanding roles in stem 
cells and development. Development 139(13):2267-2282. 
2. Valenta T, Hausmann G, & Basler K (2012) The many faces and functions of 
[beta]-catenin. EMBO Journal 31(12):2714-2736. 
3. Harris HE, Andersson U, & Pisetsky DS (2012) HMGB1: A multifunctional 
alarmin driving autoimmune and inflammatory disease. Nature Reviews 
Rheumatology 8(4):195-202. 
4. Hinz M, Arslan SC, & Scheidereit C (2012) It takes two to tango: IκBs, the 
multifunctional partners of NF-κB. Immunological Reviews 246(1):59-76. 
5. Gupta V & Bamezai RNK (2010) Human pyruvate kinase M2: A multifunctional 
protein. Protein Science 19(11):2031-2044. 
6. Zwerschke W, et al. (1999) Modulation of type M2 pyruvate kinase activity by 
the human papillomavirus type 16 E7 oncoprotein. Proceedings of the National 
Academy of Sciences 96(4):1291-1296. 
7. Zhang C, et al. (2010) P53 and p38 MAPK pathways are involved in MONCPT-
induced cell cycle G2/M arrest in human non-small cell lung cancer A549. 
Journal of Cancer Research and Clinical Oncology 136(3):437-445. 
8. Shieh S-Y, Ahn J, Tamai K, Taya Y, & Prives C (2000) The human homologs of 
checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA 




9. Vousden KH & Lu X (2002) Live or let die: the cell's response to p53. Nature 
Reviews Cancer 2(8):594-604. 
10. Ryan DP & Matthews JM (2005) Protein–protein interactions in human disease. 
Current Opinion in Structural Biology 15(4):441-446. 
11. Wong JMS, Ionescu D, & Ingles CJ (2003) Interaction between BRCA2 and 
replication protein A is compromised by a cancer-predisposing mutation in 
BRCA2. Oncogene 22(1):28-33. 
12. Jubb H, Higueruelo AP, Winter A, & Blundell TL (2012) Structural biology and 
drug discovery for protein-protein interactions. Trends in Pharmacological 
Sciences. 33(5):241-248. 
13. Hudson PJ & Souriau C (2003) Engineered antibodies. Nature Medicine 9(1):129-
134. 
14. Surade S & Blundell Tom L (2012) Structural Biology and Drug Discovery of 
Difficult Targets: The Limits of Ligandability. Chemistry & Biology 19(1):42-50. 
15. Wells JA & McClendon CL (2007) Reaching for high-hanging fruit in drug 
discovery at protein-protein interfaces. Nature 450(7172):1001-1009. 
16. Walker K & Olson MF (2005) Targeting Ras and Rho GTPases as opportunities 
for cancer therapeutics. Current Opinion in Genetics & Development 15(1):62-68. 
17. White AW, Westwell AD, & Brahemi G (2008) Protein–protein interactions as 
targets for small-molecule therapeutics in cancer. Expert Reviews in Molecular 
Medicine  





19. Erijman A, Aizner Y, & Shifman JM (2011) Multispecific Recognition: 
Mechanism, Evolution, and Design. Biochemistry 50(5):602-611. 
20. Akiva E, Itzhaki Z, & Margalit H (2008) Built-in loops allow versatility in 
domain–domain interactions: Lessons from self-interacting domains. Proceedings 
of the National Academy of Sciences 105(36):13292-13297. 
21. Fuxreiter M, Simon I, & Bondos S (2011) Dynamic protein–DNA recognition: 
beyond what can be seen. Trends in Biochemical Sciences 36(8):415-423. 
22. Graves B, et al. (2012) Activation of the p53 pathway by small-molecule-induced 
MDM2 and MDMX dimerization. Proceedings of the National Academy of 
Sciences 109(29):11788-11793. 
23. Keskin O & Nussinov R (2007) Similar Binding Sites and Different Partners: 
Implications to Shared Proteins in Cellular Pathways. Structure  15(3):341-354. 
24. Moreira IS, Fernandes PA, & Ramos MJ (2007) Hot spots—A review of the 
protein–protein interface determinant amino-acid residues. Proteins: Structure, 
Function, and Bioinformatics 68(4):803-812. 
25. Schreiber G & Keating AE (2011) Protein binding specificity versus promiscuity. 
Current Opinion in Structural Biology 21(1):50-61. 
26. Yang X, et al. (2006) Structural basis for protein–protein interactions in the 14-3-
3 protein family. Proceedings of the National Academy of Sciences 
103(46):17237-17242. 
27. Kleppe R, Martinez A, Døskeland SO, & Haavik J (2011) The 14-3-3 proteins in 





28. Baerga-Ortiz A, Bergqvist S, Mandell JG, & Komives EA (2004) Two different 
proteins that compete for binding to thrombin have opposite kinetic and 
thermodynamic profiles. Protein Science 13(1):166-176. 
29. Barker DF & Campbell AM (1981) The birA gene of Escherichia coli encodes a 
biotin holoenzyme synthetase. Journal of Molecular Biology 146(4):451-467. 
30. Barker DF & Campbell AM (1981) Genetic and biochemical characterization of 
the birA gene and its product: Evidence for a direct role of biotin holoenzyme 
synthetase in repression of the biotin operon in Escherichia coli. Journal of 
Molecular Biology 146(4):469-492. 
31. Lane MD, Rominger KL, Young DL, & Lynen F (1964) The Enzymatic Synthesis 
of Holotranscarboxylase from Apotranscarboxylase and (+)-Biotin. Journal of 
Biological Chemistry 239(9):2865-2871. 
32. Streaker ED, Gupta A, & Beckett D (2002) The Biotin Repressor:  
Thermodynamic Coupling of Corepressor Binding, Protein Assembly, and 
Sequence-Specific DNA Binding. Biochemistry 41(48):14263-14271. 
33. Streaker ED & Beckett D (2003) Coupling of Protein Assembly and DNA 
Binding: Biotin Repressor Dimerization Precedes Biotin Operator Binding. 
Journal of Molecular Biology 325(5):937-948. 
34. Li SJ & Cronan JE (1993) Growth rate regulation of Escherichia coli acetyl 
coenzyme A carboxylase, which catalyzes the first committed step of lipid 




35. Cronan JE (1988) Expression of the biotin biosynthetic operon of Escherichia coli 
is regulated by the rate of protein biotination. Journal of Biological Chemistry 
263(21):10332-10336. 
36. Wilson KP, Shewchuk LM, Brennan RG, Otsuka AJ, & Matthews BW (1992) 
Escherichia coli biotin holoenzyme synthetase/bio repressor crystal structure 
delineates the biotin- and DNA-binding domains. Proceedings of the National 
Academy of Sciences 89(19):9257-9261. 
37. Brennan RG, Vasu S, Matthews BW, & Otsuka AJ (1989) Crystallization of the 
bifunctional biotin operon repressor. Journal of Biological Chemistry 264(1):5. 
38. Weaver LH, Kwon K, Beckett D, & Matthews BW (2001) Corepressor-induced 
organization and assembly of the biotin repressor: A model for allosteric 
activation of a transcriptional regulator. Proceedings of the National Academy of 
Sciences 98(11):6045-6050. 
39. Wood ZA, Weaver LH, Brown PH, Beckett D, & Matthews BW (2006) Co-
repressor Induced Order and Biotin Repressor Dimerization: A Case for 
Divergent Followed by Convergent Evolution. Journal of Molecular Biology 
357(2):509-523. 
40. DeLano WL (2002) The PyMOL Molecular Graphics System. 
41. Tissot G, Douce R, & Alban C (1997) Evidence for multiple forms of biotin 
holocarboxylase synthetase in pea (Pisum sativum) and in Arabidopsis thaliana: 





42. Kwon K & Beckett D (2000) Function of a conserved sequence motif in biotin 
holoenzyme synthetases. Protein Science 9(8):1530-1539. 
43. Kwon K, Streaker ED, Ruparelia S, & Beckett D (2000) Multiple Disordered 
Loops Function in Corepressor-induced Dimerization of the Biotin Repressor. 
Journal of Molecular Biology 304(5):821-833. 
44. Zhao H, Naganathan S, & Beckett D (2009) Thermodynamic and Structural 
Investigation of Bispecificity in Protein–Protein Interactions. Journal of 
Molecular Biology 389(2):336-348. 
45. Athappilly FK & Hendrickson WA (1995) Structure of the biotinyl domain of 
acetyl-coenzyme A carboxylase determined by MAD phasing. Structure 
3(12):1407-1419. 
46. Nenortas E & Beckett D (1996) Purification and Characterization of Intact and 
Truncated Forms of the Escherichia coli Biotin Carboxyl Carrier Subunit of 
Acetyl-CoA Carboxylase. Journal of Biological Chemistry 271(13):7559-7567. 
47. Roberts EL, et al. (1999) Solution Structures of Apo and Holo Biotinyl Domains 
from Acetyl Coenzyme A Carboxylase of Escherichia coli Determined by Triple-
Resonance Nuclear Magnetic Resonance Spectroscopy. Biochemistry 
38(16):5045-5053. 
48. Yao X, Wei D, Soden C, Summers MF, & Beckett D (1997) Structure of the 
Carboxy-Terminal Fragment of the Apo-Biotin Carboxyl Carrier Subunit of 




49. Bagautdinov B, Matsuura Y, Bagautdinova S, & Kunishima N (2008) Protein 
Biotinylation Visualized by a Complex Structure of Biotin Protein Ligase with a 
Substrate. Journal of Biological Chemistry 283(21):14739-14750. 
50. Weaver LH, Kwon K, Beckett D, & Matthews BW (2001) Competing 
protein:protein interactions are proposed to control the biological switch of the E 
coli biotin repressor. Protein Science 10(12):2618-2622. 
51. Jitrapakdee S & Wallace JC (2003) The biotin enzyme family: conserved 
structural motifs and domain rearrangements. Current Protein and Peptide 
Science 4: 217-229. 
52. Knowles JR (1989) The Mechanism of Biotin-Dependent Enzymes. Annual 
Review of Biochemistry 58(1):195-221. 
53. Cronan Jr JE & Waldrop GL (2002) Multi-subunit acetyl-CoA carboxylases. 
Progress in Lipid Research 41(5):407-435. 
54. Tong L (2012) Structure and function of biotin-dependent carboxylases. Cellular 
and Molecular Life Sciences:1-29. 
55. Davis MS, Solbiati J, & Cronan JE (2000) Overproduction of Acetyl-CoA 
Carboxylase Activity Increases the Rate of Fatty Acid Biosynthesis in Escherichia 
coli. Journal of Biological Chemistry 275(37):28593-28598. 
56. Chapman-Smith A, Morris TW, Wallace JC, & Cronan JE (1999) Molecular 
Recognition in a Post-translational Modification of Exceptional Specificity. 




57. Soriano A, et al. (2006) Escherichia coli acetyl-coenzyme A carboxylase: 
Characterization and development of a high-throughput assay. Analytical 
Biochemistry 349(2):268-276. 
58. Abbott J & Beckett D (1993) Cooperative binding of the Escherichia coli 
repressor of biotin biosynthesis to the biotin operator sequence. Biochemistry 
32(37):9649-9656. 
59. Eisenstein E & Beckett D (1999) Dimerization of the Escherichia coli Biotin 
Repressor:  Corepressor Function in Protein Assembly. Biochemistry 
38(40):13077-13084. 
60. Otsuka A & Abelson J (1978) The regulatory region of the biotin operon in 
Escherichia coli. Nature 276(5689):689-694. 
61. Streaker ED & Beckett D (1999) Ligand-linked Structural Changes in the 
Escherichia coli Biotin Repressor: The Significance of Surface Loops for Binding 
and Allostery. Journal of Molecular Biology 292(3):619-632. 
62. Streaker ED & Beckett D (1998) A map of the biotin repressor-biotin operator 
interface: binding of a winged helix-turn-helix protein dimer to a forty base-pair 
site. Journal of Molecular Biology 278(4):787-800. 
63. Buoncristiani MR, Howard PK, & Otsuka AJ (1986) DNA-binding and enzymatic 
domains of the bifunctional biotin operon repressor (BirA) of Escherichia coli. 
Gene 44(2-3):255-261. 
64. Rusinova E, Ross JBA, Laue TM, Sowers LC, & Senear DF (1997) Linkage 
between Operator Binding and Dimer to Octamer Self-Assembly of 




65. Senear DF, et al. (1993) The primary self-assembly reaction of bacteriophage cI 
repressor dimers is to octamer. Biochemistry 32(24):6179-6189. 
66. Brown PH, Cronan JE, Grøtli M, & Beckett D (2004) The Biotin Repressor: 
Modulation of Allostery by Corepressor Analogs. Journal of Molecular Biology 
337(4):857-869. 
67. Zhao H, Streaker E, Pan W, & Beckett D (2007) Protein−Protein Interactions 
Dominate the Assembly Thermodynamics of a Transcription Repression 
Complex. Biochemistry 46(47):13667-13676. 
68. Streaker ED & Beckett D (2006) The Biotin Regulatory System:  Kinetic Control 
of a Transcriptional Switch. Biochemistry 45(20):6417-6425. 
69. Zhao H & Beckett D (2008) Kinetic Partitioning Between Alternative Protein–
Protein Interactions Controls a Transcriptional Switch. Journal of Molecular 
Biology 380(1):223-236. 
70. Rodionov DA, Mironov AA, & Gelfand MS (2002) Conservation of the Biotin 
Regulon and the BirA Regulatory Signal in Eubacteria and Archaea. Genome 
Research 12(10):1507-1516. 
71. Lombard J & Moreira D (2011) Early evolution of the biotin-dependent 
carboxylase family. BMC Evolutionary Biology 11(1):232. 
72. Larkin MA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 
23(21):2947-2948. 
73. Winget JM & Mayor T (2010) The Diversity of Ubiquitin Recognition: Hot Spots 




74. Prakash O & Eisenberg MA (1979) Biotinyl 5'-adenylate: corepressor role in the 
regulation of the biotin genes of Escherichia coli K-12. Proceedings of the 
National Academy of Sciences 76(11):5592-5595. 
75. Tron CM, et al. (2009) Structural and Functional Studies of the Biotin Protein 
Ligase from Aquifex aeolicus Reveal a Critical Role for a Conserved Residue in 
Target Specificity. Journal of Molecular Biology 387(1):129-146. 
76. Gupta V, et al. (2010) Structural Ordering of Disordered Ligand-Binding Loops 
of Biotin Protein Ligase into Active Conformations as a Consequence of 
Dehydration. PLoS ONE 5(2):e9222. 
77. Naganathan S & Beckett D (2007) Nucleation of an Allosteric Response via 
Ligand-induced Loop Folding. Journal of Molecular Biology 373(1):96-111. 
78. Gill SC & von Hippel PH (1989) Calculation of protein extinction coefficients 
from amino acid sequence data. Analytical Biochemistry 182(2):319-326. 
79. Roark DE (1976) Sedimentation equilibrium techniques: Multiple speed analyses 
and an overspeed procedure. Biophysical Chemistry 5(1–2):185-196. 
80. Johnson ML, Correia JJ, Yphantis DA, & Halvorson HR (1981) Analysis of data 
from the analytical ultracentrifuge by nonlinear least-squares techniques. 
Biophysical Journal 36(3):575-588. 
81. Laue TM (1995) Sedimentation equilibrium as thermodynamic tool. Methods in 
Enzymology 259:427-452. 
82. Ingaramo M & Beckett D (2009) Distinct Amino Termini of Two Human HCS 





83. Motulsky H & Christopoulos A (2004) Fitting Models to Biological Data Using 
Linear and Nonlinear Regression. A Practical Guide to Curve Fitting (Oxford 
University Press, New York). 
84. Xu Y & Beckett D (1994) Kinetics of Biotinyl-5'-adenylate Synthesis Catalyzed 
by the Escherichia coli Repressor of Biotin Biosynthesis and the Stability of the 
Enzyme-Product Complex. Biochemistry 33(23):7354-7360. 
85. Ingaramo M & Beckett D (2011) Biotinylation, a Post-translational Modification 
Controlled by the Rate of Protein-Protein Association. Journal of Biological 
Chemistry 286(15):13071-13078. 
86. Tungtur S, Skinner H, Zhan H, Swint-Kruse L, & Beckett D (2011) In vivo tests 
of thermodynamic models of transcription repressor function. Biophysical 
Chemistry 159(1):142-151. 
87. Hible G, et al. (2005) Calorimetric and Crystallographic Analysis of the 
Oligomeric Structure of Escherichia coli GMP Kinase. Journal of Molecular 
Biology 352(5):1044-1059. 
88. Sato K, et al. (2009) Metal-binding loop length and not sequence dictates 
structure. Proceedings of the National Academy of Sciences 106(14):5616-5621. 
89. Sakurai K & Goto Y (2002) Manipulating Monomer-Dimer Equilibrium of 
Bovine beta-Lactoglobulin by Amino Acid Substitution. Journal of Biological 
Chemistry 277(28):25735-25740. 
90. Herrou J, Rotskoff G, Luo Y, Roux B, & Crosson S (2012) Structural basis of a 




proteobacteria. Proceedings of the National Academy of Sciences 109(21):E1415–
E1423. 
91. Adikaram PR & Beckett D (2012) Functional Versatility of a Single Protein 
Surface in Two Protein:Protein Interactions. Journal of Molecular Biology 419(3–
4):223-233. 
92. Iannello R (1995) DNase I footprinting using PCR-generated end-labeled DNA 
probes. In Vitro Transcription and Translation Protocols, Methods in Molecular 
Biology 37:379-391. 
93. Wood EJ (1983) Molecular cloning. A laboratory manual by T Maniatis, E F 
Fritsch and J Sambrook. pp 545. Cold Spring Harbor Laboratory, New York. 
1982. ISBN 0-87969-136-0. Biochemical Education 11(2):82-82. 
94. Brenowitz M (1986) Quantitative DNase footprint titration: a method for studying 
protein-DNA interactions. Methods in Enzymology 130:132-181. 
95. Suzuki F, et al. (1998) Functional Interactions of Transcription Factor Human 
GA-binding Protein Subunits. Journal of Biological Chemistry 273(45):29302-
29308. 
96. Pearson JT, Dabrowski MJ, Kung I, & Atkins WM (2005) The central loop of 
Escherichia coli glutamine synthetase is flexible and functionally passive. 
Archives of Biochemistry and Biophysics 436(2):397-405. 
97. Kovalevskiy OV, Solonin AS, & Antson AA (2010) Structural investigation of 
transcriptional regulator HlyIIR: Influence of a disordered region on protein fold 





98. Kimura Y & Tanaka K (2010) Regulatory mechanisms involved in the control of 
ubiquitin homeostasis. Journal of Biochemistry 147(6):793-798. 
99. Mukhopadhyay D & Riezman H (2007) Proteasome-Independent Functions of 
Ubiquitin in Endocytosis and Signaling. Science 315(5809):201-205. 
100. Martin W (2010) Evolutionary origins of metabolic compartmentalization in 
eukaryotes. Philosophical Transactions of the Royal Society B: Biological 
Sciences 365(1541):847-855. 
101. Ingaramo M & Beckett D (2012) Selectivity in Post-translational Biotin Addition 
to Five Human Carboxylases. Journal of Biological Chemistry 287(3):1813-1822. 
102. Sharan SK, Thomason LC, Kuznetsov SG, & Court DL (2009) Recombineering: a 
homologous recombination-based method of genetic engineering. Nature 
Protocols 4(2):206-223. 
 
 
 
